Using Config: cfg_pubmed_v2_1.cfg
Runnin subconfig: HDPLDApubmed1PU
# topics: 1000
Using dataset: corpora/pubmed.txt
Scheme: ppu_hdplda_all_topics
100000
200000
300000
400000
500000
600000
700000
800000
900000
1000000
1100000
1200000
1300000
1400000
1500000
1600000
1700000
1800000
1900000
2000000
2100000
2200000
2300000
2400000
2500000
2600000
2700000
2800000
2900000
3000000
3100000
3200000
3300000
3400000
3500000
3600000
3700000
3800000
3900000
4000000
4100000
4200000
4300000
4400000
4500000
4600000
4700000
4800000
4900000
5000000
5100000
5200000
5300000
5400000
5500000
5600000
5700000
5800000
5900000
6000000
6100000
6200000
6300000
6400000
6500000
6600000
6700000
6800000
6900000
7000000
7100000
7200000
7300000
7400000
7500000
7600000
7700000
7800000
7900000
8000000
8100000
HDP gamma: 1.0
HDP start topics: 1
PoissonPolyaUrnHDPLDAInfiniteTopics Parallell HDP.
Rare word threshold: 10
Vocabulary size: 89987

Instance list is: 8199999
Loading data instances...
Config seed:4711
Start seed: 4711
Loaded 8199999 documents, with 768434972 words in total.
Starting iterations (25000 total).
_____________________________

Starting:Sun Sep 20 15:34:51 BST 2020
Active in data: 13	K = 0	Empty topics (987)
<100> Log Likelihood: -7.7780807913710985E9
Active in data: 15	K = 0	Empty topics (985)
<200> Log Likelihood: -7.755960799272517E9
Active in data: 15	K = 2	Empty topics (985)
<300> Log Likelihood: -7.734376390035708E9
Active in data: 16	K = 2	Empty topics (984)
<400> Log Likelihood: -7.728360622672773E9
Active in data: 17	K = 3	Empty topics (983)
<500> Log Likelihood: -7.712520140915858E9
Active in data: 19	K = 4	Empty topics (981)
<600> Log Likelihood: -7.674407307365763E9
Active in data: 19	K = 4	Empty topics (981)
<700> Log Likelihood: -7.635915203005762E9
Active in data: 18	K = 4	Empty topics (982)
<800> Log Likelihood: -7.613782934245575E9
Active in data: 18	K = 5	Empty topics (982)
<900> Log Likelihood: -7.598607120036043E9
Active in data: 18	K = 5	Empty topics (982)
<1000> Log Likelihood: -7.58373339123082E9
Active in data: 18	K = 5	Empty topics (982)
<1100> Log Likelihood: -7.570135194900504E9
Active in data: 22	K = 5	Empty topics (978)
<1200> Log Likelihood: -7.561034515881679E9
Active in data: 21	K = 5	Empty topics (979)
<1300> Log Likelihood: -7.554187030312317E9
Active in data: 21	K = 5	Empty topics (979)
<1400> Log Likelihood: -7.547716104699587E9
Active in data: 23	K = 5	Empty topics (977)
<1500> Log Likelihood: -7.542954104519043E9
Active in data: 24	K = 6	Empty topics (976)
<1600> Log Likelihood: -7.53762641266811E9
Active in data: 23	K = 6	Empty topics (977)
<1700> Log Likelihood: -7.529222278354967E9
Active in data: 24	K = 6	Empty topics (976)
<1800> Log Likelihood: -7.522436524341993E9
Active in data: 22	K = 6	Empty topics (978)
<1900> Log Likelihood: -7.518709748597162E9
Active in data: 24	K = 6	Empty topics (976)
<2000> Log Likelihood: -7.5153906542072525E9
Active in data: 23	K = 7	Empty topics (977)
<2100> Log Likelihood: -7.512419936455585E9
Active in data: 23	K = 7	Empty topics (977)
<2200> Log Likelihood: -7.509671917530422E9
Active in data: 23	K = 7	Empty topics (977)
<2300> Log Likelihood: -7.507022297993472E9
Active in data: 26	K = 7	Empty topics (974)
<2400> Log Likelihood: -7.503700834135675E9
Active in data: 26	K = 8	Empty topics (974)
<2500> Log Likelihood: -7.500638114418784E9
Active in data: 27	K = 8	Empty topics (973)
<2600> Log Likelihood: -7.498496025648194E9
Active in data: 26	K = 8	Empty topics (974)
<2700> Log Likelihood: -7.49680574335467E9
Active in data: 25	K = 8	Empty topics (975)
<2800> Log Likelihood: -7.495225099010072E9
Active in data: 26	K = 9	Empty topics (974)
<2900> Log Likelihood: -7.493201485781866E9
Active in data: 25	K = 9	Empty topics (975)
<3000> Log Likelihood: -7.490419103798142E9
Active in data: 25	K = 9	Empty topics (975)
<3100> Log Likelihood: -7.486980144576402E9
Active in data: 26	K = 9	Empty topics (974)
<3200> Log Likelihood: -7.48293823932233E9
Active in data: 26	K = 9	Empty topics (974)
<3300> Log Likelihood: -7.4789763841875305E9
Active in data: 29	K = 9	Empty topics (971)
<3400> Log Likelihood: -7.474971868517604E9
Active in data: 28	K = 9	Empty topics (972)
<3500> Log Likelihood: -7.470809029412763E9
Active in data: 27	K = 10	Empty topics (973)
<3600> Log Likelihood: -7.466409131070317E9
Active in data: 30	K = 10	Empty topics (970)
<3700> Log Likelihood: -7.461214086883255E9
Active in data: 30	K = 10	Empty topics (970)
<3800> Log Likelihood: -7.455480565887752E9
Active in data: 29	K = 10	Empty topics (971)
<3900> Log Likelihood: -7.449651877802619E9
Active in data: 30	K = 11	Empty topics (970)
<4000> Log Likelihood: -7.44444382911689E9
Active in data: 32	K = 11	Empty topics (968)
<4100> Log Likelihood: -7.439631628761724E9
Active in data: 33	K = 11	Empty topics (967)
<4200> Log Likelihood: -7.434677401790356E9
Active in data: 31	K = 12	Empty topics (969)
<4300> Log Likelihood: -7.429756510558994E9
Active in data: 32	K = 12	Empty topics (968)
<4400> Log Likelihood: -7.425415685240413E9
Active in data: 33	K = 12	Empty topics (967)
<4500> Log Likelihood: -7.421536168138195E9
Active in data: 33	K = 12	Empty topics (967)
<4600> Log Likelihood: -7.417729389060251E9
Active in data: 33	K = 13	Empty topics (967)
<4700> Log Likelihood: -7.41403744174143E9
Active in data: 33	K = 13	Empty topics (967)
<4800> Log Likelihood: -7.410917149451588E9
Active in data: 33	K = 13	Empty topics (967)
<4900> Log Likelihood: -7.408484190957986E9
Active in data: 32	K = 13	Empty topics (968)
<5000> Log Likelihood: -7.406396174402823E9
Active in data: 34	K = 13	Empty topics (966)
<5100> Log Likelihood: -7.404327763167564E9
Active in data: 33	K = 14	Empty topics (967)
<5200> Log Likelihood: -7.402073039596866E9
Active in data: 32	K = 14	Empty topics (968)
<5300> Log Likelihood: -7.399519049299848E9
Active in data: 35	K = 14	Empty topics (965)
<5400> Log Likelihood: -7.397060536523838E9
Active in data: 33	K = 14	Empty topics (967)
<5500> Log Likelihood: -7.394630945109694E9
Active in data: 34	K = 14	Empty topics (966)
<5600> Log Likelihood: -7.3923166801871E9
Active in data: 34	K = 14	Empty topics (966)
<5700> Log Likelihood: -7.389962630690193E9
Active in data: 36	K = 14	Empty topics (964)
<5800> Log Likelihood: -7.387908217277143E9
Active in data: 36	K = 15	Empty topics (964)
<5900> Log Likelihood: -7.386225099904439E9
Active in data: 37	K = 15	Empty topics (963)
<6000> Log Likelihood: -7.384827441589892E9
Active in data: 37	K = 15	Empty topics (963)
<6100> Log Likelihood: -7.383568852177141E9
Active in data: 37	K = 15	Empty topics (963)
<6200> Log Likelihood: -7.382349249683811E9
Active in data: 37	K = 15	Empty topics (963)
<6300> Log Likelihood: -7.381058057956342E9
Active in data: 37	K = 15	Empty topics (963)
<6400> Log Likelihood: -7.379691364595072E9
Active in data: 39	K = 15	Empty topics (961)
<6500> Log Likelihood: -7.378361653568173E9
Active in data: 37	K = 15	Empty topics (963)
<6600> Log Likelihood: -7.376949930226815E9
Active in data: 38	K = 15	Empty topics (962)
<6700> Log Likelihood: -7.37551547917918E9
Active in data: 38	K = 16	Empty topics (962)
<6800> Log Likelihood: -7.374106503632242E9
Active in data: 39	K = 16	Empty topics (961)
<6900> Log Likelihood: -7.372715822047557E9
Active in data: 38	K = 16	Empty topics (962)
<7000> Log Likelihood: -7.371367155523388E9
Active in data: 38	K = 16	Empty topics (962)
<7100> Log Likelihood: -7.369915847877768E9
Active in data: 39	K = 16	Empty topics (961)
<7200> Log Likelihood: -7.368255872527054E9
Active in data: 38	K = 16	Empty topics (962)
<7300> Log Likelihood: -7.366198832599193E9
Active in data: 38	K = 16	Empty topics (962)
<7400> Log Likelihood: -7.363858711146931E9
Active in data: 38	K = 16	Empty topics (962)
<7500> Log Likelihood: -7.3614033054046755E9
Active in data: 38	K = 17	Empty topics (962)
<7600> Log Likelihood: -7.35915631532996E9
Active in data: 38	K = 17	Empty topics (962)
<7700> Log Likelihood: -7.357543184616944E9
Active in data: 38	K = 17	Empty topics (962)
<7800> Log Likelihood: -7.356076322967175E9
Active in data: 38	K = 17	Empty topics (962)
<7900> Log Likelihood: -7.354490657774471E9
Active in data: 38	K = 17	Empty topics (962)
<8000> Log Likelihood: -7.352885604491705E9
Active in data: 38	K = 17	Empty topics (962)
<8100> Log Likelihood: -7.35129828276567E9
Active in data: 38	K = 18	Empty topics (962)
<8200> Log Likelihood: -7.34967258564432E9
Active in data: 38	K = 18	Empty topics (962)
<8300> Log Likelihood: -7.348010453561283E9
Active in data: 40	K = 18	Empty topics (960)
<8400> Log Likelihood: -7.34631040906965E9
Active in data: 39	K = 18	Empty topics (961)
<8500> Log Likelihood: -7.344252088462313E9
Active in data: 40	K = 18	Empty topics (960)
<8600> Log Likelihood: -7.341699299123437E9
Active in data: 40	K = 18	Empty topics (960)
<8700> Log Likelihood: -7.339179259792831E9
Active in data: 38	K = 19	Empty topics (962)
<8800> Log Likelihood: -7.336953041462341E9
Active in data: 39	K = 19	Empty topics (961)
<8900> Log Likelihood: -7.335010784299006E9
Active in data: 40	K = 19	Empty topics (960)
<9000> Log Likelihood: -7.333498925248086E9
Active in data: 42	K = 19	Empty topics (958)
<9100> Log Likelihood: -7.332327534441902E9
Active in data: 40	K = 19	Empty topics (960)
<9200> Log Likelihood: -7.331282236466489E9
Active in data: 40	K = 19	Empty topics (960)
<9300> Log Likelihood: -7.330530889471413E9
Active in data: 40	K = 19	Empty topics (960)
<9400> Log Likelihood: -7.329932603481676E9
Active in data: 39	K = 20	Empty topics (961)
<9500> Log Likelihood: -7.329332065817122E9
Active in data: 39	K = 20	Empty topics (961)
<9600> Log Likelihood: -7.328649959197837E9
Active in data: 38	K = 20	Empty topics (962)
<9700> Log Likelihood: -7.327754492170632E9
Active in data: 40	K = 20	Empty topics (960)
<9800> Log Likelihood: -7.326840116686345E9
Active in data: 38	K = 20	Empty topics (962)
<9900> Log Likelihood: -7.326123560568238E9
Active in data: 39	K = 20	Empty topics (961)
<10000> Log Likelihood: -7.325363008568753E9
Active in data: 39	K = 20	Empty topics (961)
<10100> Log Likelihood: -7.324642745058022E9
Active in data: 39	K = 20	Empty topics (961)
<10200> Log Likelihood: -7.323943149380637E9
Active in data: 41	K = 20	Empty topics (959)
<10300> Log Likelihood: -7.3233794214443245E9
Active in data: 40	K = 20	Empty topics (960)
<10400> Log Likelihood: -7.3229075807286415E9
Active in data: 41	K = 20	Empty topics (959)
<10500> Log Likelihood: -7.322462200820092E9
Active in data: 40	K = 20	Empty topics (960)
<10600> Log Likelihood: -7.322184519726332E9
Active in data: 39	K = 21	Empty topics (961)
<10700> Log Likelihood: -7.321949231300855E9
Active in data: 40	K = 21	Empty topics (960)
<10800> Log Likelihood: -7.321759158129171E9
Active in data: 41	K = 21	Empty topics (959)
<10900> Log Likelihood: -7.321610497139111E9
Active in data: 40	K = 21	Empty topics (960)
<11000> Log Likelihood: -7.321462786743274E9
Active in data: 41	K = 21	Empty topics (959)
<11100> Log Likelihood: -7.3212144810539055E9
Active in data: 41	K = 21	Empty topics (959)
<11200> Log Likelihood: -7.320933804065312E9
Active in data: 42	K = 21	Empty topics (958)
<11300> Log Likelihood: -7.320559057585859E9
Active in data: 42	K = 21	Empty topics (958)
<11400> Log Likelihood: -7.320086691360353E9
Active in data: 42	K = 21	Empty topics (958)
<11500> Log Likelihood: -7.319495233644579E9
Active in data: 41	K = 21	Empty topics (959)
<11600> Log Likelihood: -7.318879893899495E9
Active in data: 41	K = 21	Empty topics (959)
<11700> Log Likelihood: -7.31826134741727E9
Active in data: 42	K = 21	Empty topics (958)
<11800> Log Likelihood: -7.317699070664386E9
Active in data: 41	K = 21	Empty topics (959)
<11900> Log Likelihood: -7.317277010511343E9
Active in data: 40	K = 21	Empty topics (960)
<12000> Log Likelihood: -7.316822765854003E9
Active in data: 40	K = 21	Empty topics (960)
<12100> Log Likelihood: -7.316567660344943E9
Active in data: 40	K = 21	Empty topics (960)
<12200> Log Likelihood: -7.316171813275462E9
Active in data: 40	K = 21	Empty topics (960)
<12300> Log Likelihood: -7.315867650615883E9
Active in data: 40	K = 21	Empty topics (960)
<12400> Log Likelihood: -7.315553226660039E9
Active in data: 42	K = 21	Empty topics (958)
<12500> Log Likelihood: -7.315291407223484E9
Active in data: 41	K = 21	Empty topics (959)
<12600> Log Likelihood: -7.314998873334249E9
Active in data: 42	K = 21	Empty topics (958)
<12700> Log Likelihood: -7.314715879456439E9
Active in data: 43	K = 21	Empty topics (957)
<12800> Log Likelihood: -7.314359351896088E9
Active in data: 43	K = 21	Empty topics (957)
<12900> Log Likelihood: -7.313907576619062E9
Active in data: 42	K = 22	Empty topics (958)
<13000> Log Likelihood: -7.313450924774667E9
Active in data: 42	K = 22	Empty topics (958)
<13100> Log Likelihood: -7.312800596067528E9
Active in data: 43	K = 22	Empty topics (957)
<13200> Log Likelihood: -7.312000937222227E9
Active in data: 41	K = 22	Empty topics (959)
<13300> Log Likelihood: -7.311370099596848E9
Active in data: 42	K = 22	Empty topics (958)
<13400> Log Likelihood: -7.31084124763128E9
Active in data: 42	K = 22	Empty topics (958)
<13500> Log Likelihood: -7.310383565209995E9
Active in data: 42	K = 22	Empty topics (958)
<13600> Log Likelihood: -7.3100408103671665E9
Active in data: 44	K = 22	Empty topics (956)
<13700> Log Likelihood: -7.309696538780702E9
Active in data: 42	K = 22	Empty topics (958)
<13800> Log Likelihood: -7.309482167147659E9
Active in data: 43	K = 22	Empty topics (957)
<13900> Log Likelihood: -7.309223157998979E9
Active in data: 42	K = 22	Empty topics (958)
<14000> Log Likelihood: -7.308884936228512E9
Active in data: 42	K = 22	Empty topics (958)
<14100> Log Likelihood: -7.308403347349043E9
Active in data: 41	K = 22	Empty topics (959)
<14200> Log Likelihood: -7.30791262306642E9
Active in data: 42	K = 22	Empty topics (958)
<14300> Log Likelihood: -7.307336338588619E9
Active in data: 41	K = 22	Empty topics (959)
<14400> Log Likelihood: -7.3067001155179205E9
Active in data: 44	K = 22	Empty topics (956)
<14500> Log Likelihood: -7.305883196602244E9
Active in data: 45	K = 22	Empty topics (955)
<14600> Log Likelihood: -7.305018955508321E9
Active in data: 45	K = 23	Empty topics (955)
<14700> Log Likelihood: -7.304213255896525E9
Active in data: 45	K = 23	Empty topics (955)
<14800> Log Likelihood: -7.303348066029299E9
Active in data: 45	K = 23	Empty topics (955)
<14900> Log Likelihood: -7.302566260466137E9
Active in data: 46	K = 23	Empty topics (954)
<15000> Log Likelihood: -7.301786728924617E9
Active in data: 46	K = 23	Empty topics (954)
<15100> Log Likelihood: -7.301026100415905E9
Active in data: 46	K = 23	Empty topics (954)
<15200> Log Likelihood: -7.300291444770526E9
Active in data: 45	K = 23	Empty topics (955)
<15300> Log Likelihood: -7.299566268650438E9
Active in data: 44	K = 23	Empty topics (956)
<15400> Log Likelihood: -7.298886305352218E9
Active in data: 45	K = 23	Empty topics (955)
<15500> Log Likelihood: -7.298172483456685E9
Active in data: 45	K = 23	Empty topics (955)
<15600> Log Likelihood: -7.297579815122305E9
Active in data: 45	K = 23	Empty topics (955)
<15700> Log Likelihood: -7.297120981094029E9
Active in data: 45	K = 24	Empty topics (955)
<15800> Log Likelihood: -7.296692062080776E9
Active in data: 45	K = 24	Empty topics (955)
<15900> Log Likelihood: -7.296330291782912E9
Active in data: 46	K = 24	Empty topics (954)
<16000> Log Likelihood: -7.295923318478935E9
Active in data: 45	K = 24	Empty topics (955)
<16100> Log Likelihood: -7.295506061688956E9
Active in data: 44	K = 24	Empty topics (956)
<16200> Log Likelihood: -7.2950172146917515E9
Active in data: 43	K = 24	Empty topics (957)
<16300> Log Likelihood: -7.294450997979623E9
Active in data: 46	K = 24	Empty topics (954)
<16400> Log Likelihood: -7.293849210774903E9
Active in data: 46	K = 24	Empty topics (954)
<16500> Log Likelihood: -7.293196394252397E9
Active in data: 45	K = 24	Empty topics (955)
<16600> Log Likelihood: -7.292619483257151E9
Active in data: 45	K = 24	Empty topics (955)
<16700> Log Likelihood: -7.292102638250818E9
Active in data: 45	K = 24	Empty topics (955)
<16800> Log Likelihood: -7.291529371875236E9
Active in data: 45	K = 24	Empty topics (955)
<16900> Log Likelihood: -7.291067719176105E9
Active in data: 45	K = 24	Empty topics (955)
<17000> Log Likelihood: -7.290600292481048E9
Active in data: 47	K = 24	Empty topics (953)
<17100> Log Likelihood: -7.290276269924281E9
Active in data: 46	K = 24	Empty topics (954)
<17200> Log Likelihood: -7.289930011181789E9
Active in data: 46	K = 24	Empty topics (954)
<17300> Log Likelihood: -7.289616602107777E9
Active in data: 46	K = 25	Empty topics (954)
<17400> Log Likelihood: -7.28927350995767E9
Active in data: 47	K = 25	Empty topics (953)
<17500> Log Likelihood: -7.28897244101441E9
Active in data: 46	K = 25	Empty topics (954)
<17600> Log Likelihood: -7.288766726250444E9
Active in data: 46	K = 25	Empty topics (954)
<17700> Log Likelihood: -7.288510231469835E9
Active in data: 46	K = 25	Empty topics (954)
<17800> Log Likelihood: -7.288261977849845E9
Active in data: 46	K = 25	Empty topics (954)
<17900> Log Likelihood: -7.288113806048353E9
Active in data: 47	K = 25	Empty topics (953)
<18000> Log Likelihood: -7.287873565130204E9
Active in data: 47	K = 25	Empty topics (953)
<18100> Log Likelihood: -7.2875198341022625E9
Active in data: 46	K = 25	Empty topics (954)
<18200> Log Likelihood: -7.287159140245021E9
Active in data: 46	K = 25	Empty topics (954)
<18300> Log Likelihood: -7.2866958961528635E9
Active in data: 46	K = 25	Empty topics (954)
<18400> Log Likelihood: -7.286162517776386E9
Active in data: 47	K = 25	Empty topics (953)
<18500> Log Likelihood: -7.28575226666669E9
Active in data: 46	K = 25	Empty topics (954)
<18600> Log Likelihood: -7.285274156002007E9
Active in data: 46	K = 25	Empty topics (954)
<18700> Log Likelihood: -7.284859187486758E9
Active in data: 47	K = 25	Empty topics (953)
<18800> Log Likelihood: -7.284475119784484E9
Active in data: 49	K = 25	Empty topics (951)
<18900> Log Likelihood: -7.28405000139947E9
Active in data: 49	K = 25	Empty topics (951)
<19000> Log Likelihood: -7.2836341100489435E9
Active in data: 49	K = 26	Empty topics (951)
<19100> Log Likelihood: -7.283279215212971E9
Active in data: 50	K = 26	Empty topics (950)
<19200> Log Likelihood: -7.282920305855162E9
Active in data: 50	K = 26	Empty topics (950)
<19300> Log Likelihood: -7.282527777545572E9
Active in data: 50	K = 26	Empty topics (950)
<19400> Log Likelihood: -7.282117847601329E9
Active in data: 53	K = 26	Empty topics (947)
<19500> Log Likelihood: -7.281712977071216E9
Active in data: 52	K = 26	Empty topics (948)
<19600> Log Likelihood: -7.28116494837387E9
Active in data: 52	K = 26	Empty topics (948)
<19700> Log Likelihood: -7.280595198979931E9
Active in data: 52	K = 26	Empty topics (948)
<19800> Log Likelihood: -7.2798795368502865E9
Active in data: 52	K = 26	Empty topics (948)
<19900> Log Likelihood: -7.279091563084639E9
Active in data: 51	K = 26	Empty topics (949)
<20000> Log Likelihood: -7.278316495677388E9
Active in data: 51	K = 26	Empty topics (949)
<20100> Log Likelihood: -7.277575240595924E9
Active in data: 51	K = 26	Empty topics (949)
<20200> Log Likelihood: -7.276820524927437E9
Active in data: 51	K = 26	Empty topics (949)
<20300> Log Likelihood: -7.27600394267405E9
Active in data: 51	K = 26	Empty topics (949)
<20400> Log Likelihood: -7.275502042899517E9
Active in data: 51	K = 26	Empty topics (949)
<20500> Log Likelihood: -7.275048435110489E9
Active in data: 52	K = 26	Empty topics (948)
<20600> Log Likelihood: -7.27471173180811E9
Active in data: 51	K = 26	Empty topics (949)
<20700> Log Likelihood: -7.274378863396128E9
Active in data: 51	K = 26	Empty topics (949)
<20800> Log Likelihood: -7.2741027894375105E9
Active in data: 51	K = 26	Empty topics (949)
<20900> Log Likelihood: -7.273770661402654E9
Active in data: 52	K = 26	Empty topics (948)
<21000> Log Likelihood: -7.273466000611185E9
Active in data: 51	K = 26	Empty topics (949)
<21100> Log Likelihood: -7.27320247350271E9
Active in data: 52	K = 26	Empty topics (948)
<21200> Log Likelihood: -7.272901791962357E9
Active in data: 52	K = 26	Empty topics (948)
<21300> Log Likelihood: -7.272604271737666E9
Active in data: 53	K = 26	Empty topics (947)
<21400> Log Likelihood: -7.272230582515183E9
Active in data: 52	K = 26	Empty topics (948)
<21500> Log Likelihood: -7.271882789576407E9
Active in data: 51	K = 26	Empty topics (949)
<21600> Log Likelihood: -7.271631995475776E9
Active in data: 52	K = 26	Empty topics (948)
<21700> Log Likelihood: -7.271253921649637E9
Active in data: 52	K = 27	Empty topics (948)
<21800> Log Likelihood: -7.2709916562764845E9
Active in data: 52	K = 27	Empty topics (948)
<21900> Log Likelihood: -7.270574585459514E9
Active in data: 53	K = 27	Empty topics (947)
<22000> Log Likelihood: -7.270157829336847E9
Active in data: 52	K = 27	Empty topics (948)
<22100> Log Likelihood: -7.269714222550491E9
Active in data: 52	K = 27	Empty topics (948)
<22200> Log Likelihood: -7.269195301878971E9
Active in data: 52	K = 27	Empty topics (948)
<22300> Log Likelihood: -7.26861787277739E9
Active in data: 52	K = 27	Empty topics (948)
<22400> Log Likelihood: -7.267978336637493E9
Active in data: 52	K = 27	Empty topics (948)
<22500> Log Likelihood: -7.267136135475387E9
Active in data: 52	K = 27	Empty topics (948)
<22600> Log Likelihood: -7.26617869814949E9
Active in data: 51	K = 27	Empty topics (949)
<22700> Log Likelihood: -7.265079704530871E9
Active in data: 53	K = 27	Empty topics (947)
<22800> Log Likelihood: -7.263989450365012E9
Active in data: 54	K = 28	Empty topics (946)
<22900> Log Likelihood: -7.262779179938581E9
Active in data: 54	K = 28	Empty topics (946)
<23000> Log Likelihood: -7.261676776817234E9
Active in data: 53	K = 28	Empty topics (947)
<23100> Log Likelihood: -7.260518395153169E9
Active in data: 53	K = 28	Empty topics (947)
<23200> Log Likelihood: -7.2595897870870075E9
Active in data: 53	K = 28	Empty topics (947)
<23300> Log Likelihood: -7.25879617820211E9
Active in data: 53	K = 28	Empty topics (947)
<23400> Log Likelihood: -7.258131205532988E9
Active in data: 53	K = 28	Empty topics (947)
<23500> Log Likelihood: -7.257646492312229E9
Active in data: 53	K = 28	Empty topics (947)
<23600> Log Likelihood: -7.25717257049604E9
Active in data: 53	K = 28	Empty topics (947)
<23700> Log Likelihood: -7.256893597232634E9
Active in data: 53	K = 28	Empty topics (947)
<23800> Log Likelihood: -7.256615300476518E9
Active in data: 53	K = 29	Empty topics (947)
<23900> Log Likelihood: -7.25633926111466E9
Active in data: 54	K = 29	Empty topics (946)
<24000> Log Likelihood: -7.2561605696391E9
Active in data: 53	K = 29	Empty topics (947)
<24100> Log Likelihood: -7.255958902807934E9
Active in data: 53	K = 29	Empty topics (947)
<24200> Log Likelihood: -7.255825978263123E9
Active in data: 53	K = 29	Empty topics (947)
<24300> Log Likelihood: -7.255623418140174E9
Active in data: 53	K = 29	Empty topics (947)
<24400> Log Likelihood: -7.255389468811625E9
Active in data: 53	K = 29	Empty topics (947)
<24500> Log Likelihood: -7.255218265205643E9
Active in data: 53	K = 29	Empty topics (947)
<24600> Log Likelihood: -7.25497101569973E9
Active in data: 52	K = 29	Empty topics (948)
<24700> Log Likelihood: -7.254727321904841E9
Active in data: 53	K = 29	Empty topics (947)
<24800> Log Likelihood: -7.254472511653044E9
Active in data: 54	K = 29	Empty topics (946)
<24900> Log Likelihood: -7.254210486413368E9
Active in data: 54	K = 29	Empty topics (946)
<25000> Log Likelihood: -7.253882784279722E9
Finished:Thu Sep 24 06:17:44 BST 2020
Top words are: 
Topic 1: care health patient medical research clinical system cost hospital program physician data information practice management problem based development quality treatment
Topic 2: gene dna protein sequence expression rna genes region sequences human mrna cell promoter acid transcription analysis cdna amino site binding
Topic 3: model data system analysis measurement time based parameter field distribution values function effect set test dynamic number experimental approach error
Topic 4: risk age year women children factor population mortality ci prevalence data smoking health incidence disease rates confidence death aged hospital
Topic 5: patient treatment mg drug effect dose day therapy trial placebo week clinical treated administration efficacy kg oral month doses group
Topic 6: cell cd mice antigen il lymphocytes immune blood response human gamma marrow ifn peripheral responses lymphocyte expression class vitro anti
Topic 7: patient surgery surgical complication treatment postoperative year operation procedure technique month catheter day management operative procedures hospital treated underwent abdominal
Topic 8: cell growth expression factor alpha beta il human effect mrna receptor apoptosis endothelial induced protein level tnf proliferation fibroblast production
Topic 9: protein cell kinase receptor expression activation pathway phosphorylation binding factor activity domain function signaling gene signal tyrosine regulation transcription mechanism
Topic 10: structure binding protein reaction interaction acid complex compound site form crystal chain residues formation ph complexes structural molecular ion state
Topic 11: patient disorder children symptom depression social treatment behavior factor scores life test scale health pain cognitive anxiety relationship psychiatric problem
Topic 12: protein binding human acid antibodies alpha gel peptide kda cell purified antibody molecular membrane activity affinity receptor amino beta peptides
Topic 13: patient disease syndrome clinical diagnosis year treatment symptom disorder lesion children acute severe therapy presented chronic features rare diseases literature
Topic 14: cell electron microscopy neuron layer fiber rat membrane distribution nucleus tissue development region number surface pattern nerve day axon staining
Topic 15: patient cancer tumor survival breast treatment carcinoma year disease chemotherapy therapy stage cell prostate tumour month treated clinical metastases primary
Topic 16: blood pressure flow rat effect min arterial hypertension renal plasma control heart vascular infusion angiotensin rate dog hypertensive ml kg
Topic 17: cell rat effect liver activity induced dna mice dose drug level treatment human damage concentration exposure mg animal vitro agent
Topic 18: insulin glucose diet level cholesterol diabetes plasma diabetic rat effect concentration control fat weight acid body serum intake lipoprotein lipid
Topic 19: ca cell channel effect calcium concentration na current induced microm receptor membrane dependent release muscle intracellular potential mm rat camp
Topic 20: receptor rat effect induced kg antagonist mg dopamine activity brain neuron agonist administration ht injection binding dose drug response stimulation
Topic 21: bone patient joint implant fractures treatment fracture hip tissue dental year knee teeth cartilage mm clinical material mineral femoral anterior
Topic 22: acid activity enzyme concentration liver rat synthesis cell enzymes effect glucose fatty inhibition atp dehydrogenase metabolism mitochondrial amino transport substrate
Topic 23: visual task effect memory response movement sleep stimuli stimulus responses frequency hearing experiment cortex activity stimulation auditory potential test performance
Topic 24: patient coronary artery heart myocardial left ventricular cardiac disease infarction aortic valve acute bypass pulmonary stroke year stenosis arteries carotid
Topic 25: infection virus hiv strain infected immunodeficiency antibiotic isolates viral patient human positive type resistance resistant clinical bacterial viruses test isolated
Topic 26: assay concentration samples detection liquid chromatography determination acid solution ml analysis plasma phase mass drug performance system degrees urine test
Topic 27: patient renal serum level liver disease hepatitis chronic transplantation transplant antibodies donor control anti acute positive kidney hcv blood igg
Topic 28: hormone level rat effect concentration day serum thyroid estrogen pituitary receptor gh growth plasma lh secretion treatment progesterone steroid testosterone
Topic 29: cell tumor expression cancer carcinoma human patient normal tumour malignant leukemia lines positive carcinomas tissue dna analysis lymphoma breast lesion
Topic 30: water concentration exposure effect level soil samples plant compound extract chemical food metal content air lead product mg organic environmental
Topic 31: patient imaging ct resonance lesion tomography mri magnetic diagnosis scan tumor images contrast computed cerebral clinical examination brain diagnostic ultrasound
Topic 32: mutation gene genetic polymorphism chromosome patient analysis genes population allele region disease dna marker family individual locus alleles genotype families
Topic 33: muscle exercise nerve degrees muscles activity temperature training control motor effect stimulation skeletal test force min body fiber pain time
Topic 34: species infection animal egg population infected host parasite malaria dog adult fish larvae cattle bird number control day parasites human
Topic 35: infant pregnancy fetal women birth maternal day sperm pregnant age mother neonatal gestation weight newborn week delivery gestational development rate
Topic 36: platelet blood factor cell neutrophil activity plasma effect iron level human inhibitor concentration heparin induced prostaglandin activation thrombin aggregation release
Topic 37: strain coli mutant gene cell escherichia protein growth bacteria plasmid type genes bacterial acid activity wild yeast isolated expression resistance
Topic 38: lung pulmonary patient respiratory asthma airway ventilation oxygen nasal allergic pressure test function bronchial allergen chronic ige alveolar effect volume
Topic 39: brain neuron nervous disease neuronal rat system injury ad cord cerebral spinal alzheimer cell protein cn central mice nerve cortex
Topic 40: gastric patient intestinal bile pancreatic pylori ulcer bowel mucosa disease duct gastrointestinal mucosal acid small colon secretion biliary intestine stomach
Topic 41: skin patient eyes laser eye retinal visual corneal len ocular wound treatment cataract glaucoma intraocular acuity surgery optic month normal
Topic 42: heart patient ventricular cardiac atrial rate tachycardia fibrillation pacing left interval arrhythmias sinus ecg block conduction failure af myocardial lead
Topic 43: plant light melatonin circadian rhythm root arabidopsis level dark seed activity growth leaves expression chloroplast leaf mutant species cell rice
Topic 44: ii group control iii type significantly pc sp pd iv cp lt level cr values pt ap lower ac ar
Topic 45: patient tuberculosis diagnosis pulmonary lung pleural mycobacterium cyst positive infection test effusion tb disease biopsy chest clinical fluid lesion diagnostic
Topic 46: toxin vaccine vaccination antibody immunization antigen vaccines antibodies mice response venom strain immune responses pertussis injection serum protection igg animal
Topic 47: copper taurine lymphatic sam csa hap abp lec rat pmp mec cyclosporin mpt pcm wilson mta iron cga vocal fold
Topic 48: hr spraying drift collar vacm interscan iir mssp rofecoxib variability los calprotectin enameloid chimeric ddt ipac insecticide night icon gonorrhoea
Topic 49: ocp oa seeking thr polio kitakyushu bsa microg apatite histamine lowest survivor rhbmp apl settlement purpurascen krb ohp list viscoelasticity
Topic 50: phenolphthalein lta bicarbonate fuch sodium tsd endothelium glucuronide pi suggesting exd electrogastrography mechanistically jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib
Topic 51: gp phosphorylcholine tgi ges conductance dilution saline sey photoelectron yielding released work jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin
Topic 52: hrk jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas
Topic 53: psw jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas
Topic 54: hyperkalemia jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas
Topic 55: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 56: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 57: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 58: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 59: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 60: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 61: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 62: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 63: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 64: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 65: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 66: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 67: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 68: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 69: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 70: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 71: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 72: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 73: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 74: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 75: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 76: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 77: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 78: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 79: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 80: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 81: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 82: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 83: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 84: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 85: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 86: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 87: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 88: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 89: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 90: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 91: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 92: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 93: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 94: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 95: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 96: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 97: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 98: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 99: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 100: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 101: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 102: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 103: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 104: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 105: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 106: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 107: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 108: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 109: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 110: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 111: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 112: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 113: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 114: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 115: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 116: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 117: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 118: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 119: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 120: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 121: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 122: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 123: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 124: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 125: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 126: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 127: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 128: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 129: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 130: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 131: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 132: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 133: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 134: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 135: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 136: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 137: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 138: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 139: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 140: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 141: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 142: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 143: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 144: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 145: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 146: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 147: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 148: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 149: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 150: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 151: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 152: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 153: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 154: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 155: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 156: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 157: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 158: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 159: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 160: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 161: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 162: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 163: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 164: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 165: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 166: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 167: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 168: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 169: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 170: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 171: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 172: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 173: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 174: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 175: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 176: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 177: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 178: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 179: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 180: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 181: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 182: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 183: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 184: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 185: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 186: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 187: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 188: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 189: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 190: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 191: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 192: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 193: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 194: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 195: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 196: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 197: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 198: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 199: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 200: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 201: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 202: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 203: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 204: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 205: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 206: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 207: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 208: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 209: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 210: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 211: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 212: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 213: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 214: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 215: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 216: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 217: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 218: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 219: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 220: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 221: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 222: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 223: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 224: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 225: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 226: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 227: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 228: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 229: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 230: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 231: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 232: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 233: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 234: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 235: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 236: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 237: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 238: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 239: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 240: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 241: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 242: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 243: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 244: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 245: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 246: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 247: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 248: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 249: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 250: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 251: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 252: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 253: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 254: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 255: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 256: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 257: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 258: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 259: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 260: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 261: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 262: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 263: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 264: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 265: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 266: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 267: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 268: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 269: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 270: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 271: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 272: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 273: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 274: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 275: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 276: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 277: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 278: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 279: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 280: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 281: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 282: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 283: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 284: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 285: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 286: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 287: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 288: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 289: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 290: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 291: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 292: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 293: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 294: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 295: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 296: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 297: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 298: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 299: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 300: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 301: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 302: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 303: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 304: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 305: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 306: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 307: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 308: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 309: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 310: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 311: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 312: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 313: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 314: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 315: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 316: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 317: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 318: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 319: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 320: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 321: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 322: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 323: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 324: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 325: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 326: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 327: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 328: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 329: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 330: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 331: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 332: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 333: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 334: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 335: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 336: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 337: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 338: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 339: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 340: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 341: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 342: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 343: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 344: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 345: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 346: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 347: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 348: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 349: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 350: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 351: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 352: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 353: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 354: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 355: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 356: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 357: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 358: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 359: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 360: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 361: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 362: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 363: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 364: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 365: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 366: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 367: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 368: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 369: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 370: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 371: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 372: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 373: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 374: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 375: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 376: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 377: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 378: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 379: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 380: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 381: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 382: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 383: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 384: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 385: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 386: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 387: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 388: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 389: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 390: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 391: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 392: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 393: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 394: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 395: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 396: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 397: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 398: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 399: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 400: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 401: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 402: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 403: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 404: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 405: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 406: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 407: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 408: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 409: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 410: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 411: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 412: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 413: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 414: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 415: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 416: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 417: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 418: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 419: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 420: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 421: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 422: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 423: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 424: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 425: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 426: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 427: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 428: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 429: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 430: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 431: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 432: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 433: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 434: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 435: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 436: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 437: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 438: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 439: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 440: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 441: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 442: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 443: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 444: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 445: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 446: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 447: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 448: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 449: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 450: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 451: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 452: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 453: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 454: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 455: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 456: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 457: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 458: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 459: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 460: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 461: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 462: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 463: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 464: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 465: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 466: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 467: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 468: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 469: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 470: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 471: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 472: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 473: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 474: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 475: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 476: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 477: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 478: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 479: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 480: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 481: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 482: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 483: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 484: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 485: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 486: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 487: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 488: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 489: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 490: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 491: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 492: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 493: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 494: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 495: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 496: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 497: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 498: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 499: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 500: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 501: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 502: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 503: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 504: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 505: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 506: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 507: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 508: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 509: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 510: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 511: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 512: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 513: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 514: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 515: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 516: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 517: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 518: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 519: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 520: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 521: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 522: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 523: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 524: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 525: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 526: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 527: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 528: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 529: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 530: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 531: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 532: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 533: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 534: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 535: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 536: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 537: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 538: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 539: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 540: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 541: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 542: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 543: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 544: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 545: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 546: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 547: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 548: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 549: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 550: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 551: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 552: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 553: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 554: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 555: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 556: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 557: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 558: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 559: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 560: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 561: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 562: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 563: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 564: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 565: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 566: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 567: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 568: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 569: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 570: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 571: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 572: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 573: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 574: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 575: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 576: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 577: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 578: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 579: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 580: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 581: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 582: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 583: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 584: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 585: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 586: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 587: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 588: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 589: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 590: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 591: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 592: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 593: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 594: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 595: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 596: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 597: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 598: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 599: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 600: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 601: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 602: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 603: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 604: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 605: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 606: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 607: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 608: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 609: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 610: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 611: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 612: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 613: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 614: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 615: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 616: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 617: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 618: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 619: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 620: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 621: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 622: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 623: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 624: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 625: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 626: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 627: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 628: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 629: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 630: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 631: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 632: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 633: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 634: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 635: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 636: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 637: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 638: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 639: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 640: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 641: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 642: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 643: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 644: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 645: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 646: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 647: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 648: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 649: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 650: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 651: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 652: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 653: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 654: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 655: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 656: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 657: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 658: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 659: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 660: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 661: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 662: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 663: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 664: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 665: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 666: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 667: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 668: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 669: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 670: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 671: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 672: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 673: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 674: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 675: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 676: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 677: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 678: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 679: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 680: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 681: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 682: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 683: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 684: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 685: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 686: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 687: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 688: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 689: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 690: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 691: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 692: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 693: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 694: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 695: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 696: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 697: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 698: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 699: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 700: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 701: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 702: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 703: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 704: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 705: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 706: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 707: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 708: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 709: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 710: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 711: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 712: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 713: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 714: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 715: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 716: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 717: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 718: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 719: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 720: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 721: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 722: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 723: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 724: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 725: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 726: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 727: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 728: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 729: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 730: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 731: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 732: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 733: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 734: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 735: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 736: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 737: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 738: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 739: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 740: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 741: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 742: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 743: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 744: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 745: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 746: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 747: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 748: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 749: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 750: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 751: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 752: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 753: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 754: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 755: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 756: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 757: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 758: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 759: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 760: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 761: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 762: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 763: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 764: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 765: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 766: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 767: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 768: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 769: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 770: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 771: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 772: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 773: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 774: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 775: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 776: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 777: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 778: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 779: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 780: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 781: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 782: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 783: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 784: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 785: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 786: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 787: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 788: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 789: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 790: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 791: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 792: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 793: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 794: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 795: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 796: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 797: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 798: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 799: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 800: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 801: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 802: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 803: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 804: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 805: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 806: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 807: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 808: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 809: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 810: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 811: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 812: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 813: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 814: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 815: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 816: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 817: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 818: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 819: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 820: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 821: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 822: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 823: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 824: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 825: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 826: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 827: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 828: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 829: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 830: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 831: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 832: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 833: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 834: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 835: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 836: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 837: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 838: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 839: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 840: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 841: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 842: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 843: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 844: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 845: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 846: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 847: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 848: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 849: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 850: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 851: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 852: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 853: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 854: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 855: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 856: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 857: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 858: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 859: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 860: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 861: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 862: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 863: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 864: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 865: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 866: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 867: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 868: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 869: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 870: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 871: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 872: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 873: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 874: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 875: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 876: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 877: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 878: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 879: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 880: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 881: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 882: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 883: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 884: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 885: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 886: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 887: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 888: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 889: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 890: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 891: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 892: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 893: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 894: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 895: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 896: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 897: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 898: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 899: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 900: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 901: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 902: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 903: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 904: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 905: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 906: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 907: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 908: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 909: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 910: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 911: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 912: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 913: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 914: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 915: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 916: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 917: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 918: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 919: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 920: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 921: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 922: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 923: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 924: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 925: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 926: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 927: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 928: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 929: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 930: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 931: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 932: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 933: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 934: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 935: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 936: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 937: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 938: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 939: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 940: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 941: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 942: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 943: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 944: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 945: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 946: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 947: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 948: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 949: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 950: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 951: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 952: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 953: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 954: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 955: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 956: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 957: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 958: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 959: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 960: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 961: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 962: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 963: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 964: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 965: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 966: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 967: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 968: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 969: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 970: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 971: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 972: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 973: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 974: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 975: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 976: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 977: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 978: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 979: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 980: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 981: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 982: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 983: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 984: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 985: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 986: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 987: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 988: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 989: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 990: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 991: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 992: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 993: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 994: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 995: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 996: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 997: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 998: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 999: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 1000: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Relevance words are: 
Topic 1: care health medical cost research physician program practice nursing services hospital information management nurses medicine education quality problem public decision
Topic 2: dna gene rna sequence sequences genes region cdna promoter protein expression mrna transcription polymerase transcript genome vector element replication genomic
Topic 3: model data measurement system parameter simulation algorithm field analysis equation image error computer prediction based set dynamic time distribution beam
Topic 4: risk age year women ci children smoking prevalence population mortality confidence factor aged incidence older cohort smoker death rates sex
Topic 5: treatment mg patient drug dose placebo trial therapy day efficacy randomized effect week oral controlled pharmacokinetic daily administration doses blind
Topic 6: cell cd mice lymphocytes immune il antigen marrow ifn lymphocyte gamma nk mononuclear mhc spleen peripheral class macrophages stem csf
Topic 7: patient surgery complication surgical postoperative operation laparoscopic catheter operative procedure trauma abdominal bladder procedures vein treatment underwent technique incontinence injuries
Topic 8: cell growth expression il apoptosis tnf alpha endothelial beta factor mrna tgf fibroblast proliferation mmp necrosis vegf adhesion human interleukin
Topic 9: kinase protein phosphorylation signaling activation cell pathway receptor tyrosine domain expression pkc hsp kinases transcription signal binding regulation erk nuclear
Topic 10: structure crystal nmr binding conformation bond interaction reaction complexes residues conformational spectroscopy compound spectra ion ligand structural atom hydrogen transition
Topic 11: disorder depression social anxiety psychiatric scores symptom cognitive children psychological scale mental behavior schizophrenia adolescent personality abuse depressive rating sexual
Topic 12: protein binding kda gel purified antibodies peptide affinity peptides glycoprotein antibody monoclonal subunit molecular acid sulfate amino alpha electrophoresis bound
Topic 13: syndrome patient disease diagnosis clinical symptom disorder year manifestation rare lesion features severe literature sign presented congenital children acute epilepsy
Topic 14: cell electron microscopy layer fiber axon neuron nucleus ultrastructural nuclei granules epithelium staining distribution microscopic section filament junction ganglion bodies
Topic 15: cancer tumor patient breast survival chemotherapy carcinoma prostate metastases radiotherapy stage lymph metastatic recurrence node metastasis tumour radiation therapy treatment
Topic 16: pressure blood flow hypertension arterial angiotensin min hypertensive renin renal rat infusion reperfusion dog hg vascular ischemia mmhg heart perfusion
Topic 17: rat liver glutathione antioxidant oxidative effect damage induced mice radical gsh cell superoxide peroxidation dna activity dose sod ho exposure
Topic 18: insulin diet glucose cholesterol diabetes diabetic fat lipoprotein dietary fed intake vitamin ldl plasma lipid weight hdl body level islet
Topic 19: ca channel calcium na microm current camp cyclase voltage intracellular cai cyclic release membrane contraction dependent effect atpase concentration amp
Topic 20: receptor rat dopamine antagonist effect agonist ht gaba nmda opioid kg serotonin da morphine neuron cocaine induced ethanol glutamate brain
Topic 21: bone joint fractures implant fracture hip teeth dental knee cartilage ligament mineral tooth femoral mandibular bmd periodontal tendon spine fixation
Topic 22: acid enzyme activity dehydrogenase mitochondrial fatty atp enzymes phosphate substrate mitochondria coa reductase metabolism oxidase transport km synthesis uptake glucose
Topic 23: task visual memory hearing auditory stimulus stimuli sleep eeg movement word speech cortex learning temporal evoked spatial motor processing noise
Topic 24: coronary artery myocardial heart ventricular left infarction valve aortic cardiac patient bypass mitral echocardiography stenosis stroke carotid arteries lv angina
Topic 25: infection virus hiv infected immunodeficiency isolates antibiotic viral strain viruses simplex hsv antimicrobial herpes aureus resistant mic bacterial staphylococcus pneumoniae
Topic 26: liquid assay chromatography detection samples determination spectrometry solution urine column hplc separation concentration chromatographic extraction mass performance ml phase ph
Topic 27: patient renal hepatitis serum transplantation transplant liver hcv dialysis chronic recipient lupus donor cirrhosis level disease igg rejection hbv antibodies
Topic 28: hormone estrogen pituitary gh thyroid lh progesterone testosterone estradiol cortisol level steroid prolactin androgen adrenal acth fsh hormones tsh igf
Topic 29: tumor cell carcinoma carcinomas cancer leukemia hpv expression malignant tumour lymphoma squamous lines ebv immunohistochemical neoplastic lymphomas aml staining myeloid
Topic 30: water soil exposure concentration plant metal extract air sediment chemical organic food mercury pcb oil environmental pollution contamination compound samples
Topic 31: imaging ct resonance tomography mri scan magnetic images computed mr lesion pet ultrasound patient intracranial diagnosis spect cerebral weighted angiography
Topic 32: mutation genetic polymorphism gene chromosome allele alleles genotype loci locus linkage families genes deletion genotypes autosomal hla homozygous population familial
Topic 33: muscle exercise muscles nerve degrees temperature training skeletal force motor emg leg athletes walking limb contraction fiber vo endurance muscular
Topic 34: species parasite malaria egg larvae parasites bird cattle falciparum plasmodium tick fish host worm infection animal infected insect herd cow
Topic 35: pregnancy infant fetal birth maternal sperm pregnant gestation women mother neonatal newborn gestational pregnancies preterm fetuses prenatal uterine delivery abortion
Topic 36: platelet neutrophil iron thrombin heparin blood prostaglandin pmn aggregation plasminogen pge fibrinogen coagulation paf rbc transfusion factor plasma red fibrin
Topic 37: strain coli mutant escherichia plasmid bacteria bacillus bacterial subtilis operon yeast pseudomonas gene virulence wild cerevisiae growth bacterium genes salmonella
Topic 38: lung asthma airway pulmonary respiratory ventilation allergen allergic nasal bronchial breathing asthmatic ige alveolar expiratory inhaled fev inhalation allergy oxygen
Topic 39: brain nervous neuron neuronal ad alzheimer cn cord amyloid astrocytes glial spinal ngf cerebral injury myelin dementia disease cortex abeta
Topic 40: gastric intestinal bile pylori ulcer bowel pancreatic mucosa mucosal duct duodenal pancreatitis gastrointestinal biliary intestine stomach colon colitis colonic helicobacter
Topic 41: eyes retinal skin laser corneal eye len ocular cataract visual glaucoma intraocular acuity wound lenses burn macular optic iop topical
Topic 42: ventricular atrial heart cardiac fibrillation tachycardia pacing arrhythmias af ecg pacemaker conduction av antiarrhythmic beat qt sinus arrhythmia digoxin ablation
Topic 43: plant melatonin circadian light arabidopsis rhythm chloroplast leaf seed dark leaves pineal root rice seedling maize thaliana tomato scn photoreceptor
Topic 44: ii cp group pc pd iii pt cr sp pe ac ss mp mc ep pp ar la np iv
Topic 45: tuberculosis mycobacterium pleural tb effusion bcg cyst leprosy tuberculous pulmonary smear mycobacterial mycobacteria chest diagnosis avium asbestos mesothelioma carinii aspiration
Topic 46: toxin vaccine vaccination immunization venom vaccines pertussis vaccinated botulinum cholera tetanus immunized antibody enterotoxin diphtheria difficile cholerae clostridium antigen adjuvant
Topic 47: hap lec taurine sam abp pmp lymphatic mpt mec pcm copper mta dmt prc pcn cpn hbp cga msd wilson
Topic 48: vacm mssp interscan iir spraying enameloid ipac photoincorporation drift collar calprotectin icon rofecoxib gjc serr hr drifted fame extracoronary pif
Topic 49: ocp kitakyushu purpurascen krb oa polio thr rhbmp seeking photosensitisation apatite settlement ohp viscoelasticity apl bsa rook iceland diarrhetic icelandic
Topic 50: phenolphthalein lta fuch tsd bicarbonate glucuronide exd endothelium electrogastrography sodium mechanistically pi suggesting lict caec drotaa cydab tigemonam aidb phaso
Topic 51: tgi phosphorylcholine ges sey gp conductance photoelectron dilution yielding saline released work lict caec drotaa cydab tigemonam aidb phaso gkd
Topic 52: hrk lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss
Topic 53: psw lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss
Topic 54: hyperkalemia lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss
Topic 55: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 56: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 57: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 58: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 59: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 60: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 61: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 62: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 63: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 64: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 65: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 66: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 67: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 68: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 69: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 70: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 71: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 72: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 73: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 74: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 75: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 76: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 77: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 78: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 79: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 80: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 81: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 82: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 83: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 84: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 85: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 86: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 87: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 88: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 89: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 90: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 91: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 92: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 93: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 94: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 95: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 96: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 97: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 98: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 99: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 100: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 101: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 102: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 103: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 104: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 105: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 106: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 107: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 108: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 109: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 110: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 111: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 112: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 113: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 114: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 115: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 116: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 117: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 118: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 119: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 120: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 121: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 122: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 123: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 124: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 125: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 126: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 127: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 128: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 129: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 130: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 131: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 132: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 133: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 134: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 135: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 136: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 137: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 138: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 139: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 140: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 141: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 142: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 143: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 144: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 145: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 146: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 147: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 148: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 149: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 150: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 151: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 152: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 153: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 154: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 155: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 156: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 157: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 158: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 159: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 160: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 161: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 162: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 163: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 164: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 165: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 166: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 167: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 168: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 169: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 170: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 171: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 172: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 173: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 174: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 175: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 176: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 177: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 178: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 179: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 180: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 181: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 182: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 183: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 184: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 185: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 186: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 187: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 188: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 189: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 190: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 191: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 192: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 193: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 194: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 195: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 196: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 197: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 198: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 199: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 200: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 201: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 202: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 203: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 204: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 205: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 206: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 207: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 208: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 209: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 210: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 211: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 212: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 213: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 214: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 215: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 216: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 217: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 218: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 219: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 220: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 221: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 222: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 223: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 224: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 225: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 226: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 227: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 228: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 229: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 230: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 231: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 232: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 233: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 234: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 235: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 236: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 237: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 238: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 239: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 240: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 241: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 242: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 243: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 244: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 245: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 246: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 247: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 248: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 249: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 250: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 251: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 252: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 253: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 254: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 255: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 256: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 257: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 258: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 259: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 260: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 261: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 262: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 263: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 264: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 265: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 266: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 267: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 268: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 269: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 270: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 271: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 272: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 273: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 274: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 275: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 276: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 277: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 278: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 279: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 280: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 281: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 282: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 283: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 284: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 285: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 286: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 287: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 288: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 289: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 290: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 291: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 292: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 293: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 294: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 295: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 296: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 297: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 298: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 299: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 300: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 301: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 302: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 303: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 304: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 305: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 306: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 307: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 308: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 309: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 310: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 311: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 312: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 313: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 314: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 315: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 316: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 317: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 318: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 319: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 320: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 321: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 322: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 323: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 324: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 325: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 326: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 327: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 328: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 329: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 330: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 331: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 332: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 333: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 334: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 335: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 336: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 337: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 338: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 339: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 340: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 341: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 342: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 343: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 344: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 345: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 346: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 347: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 348: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 349: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 350: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 351: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 352: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 353: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 354: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 355: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 356: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 357: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 358: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 359: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 360: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 361: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 362: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 363: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 364: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 365: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 366: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 367: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 368: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 369: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 370: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 371: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 372: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 373: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 374: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 375: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 376: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 377: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 378: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 379: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 380: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 381: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 382: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 383: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 384: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 385: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 386: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 387: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 388: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 389: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 390: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 391: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 392: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 393: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 394: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 395: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 396: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 397: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 398: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 399: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 400: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 401: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 402: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 403: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 404: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 405: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 406: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 407: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 408: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 409: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 410: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 411: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 412: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 413: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 414: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 415: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 416: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 417: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 418: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 419: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 420: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 421: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 422: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 423: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 424: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 425: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 426: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 427: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 428: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 429: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 430: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 431: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 432: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 433: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 434: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 435: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 436: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 437: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 438: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 439: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 440: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 441: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 442: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 443: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 444: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 445: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 446: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 447: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 448: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 449: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 450: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 451: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 452: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 453: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 454: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 455: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 456: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 457: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 458: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 459: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 460: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 461: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 462: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 463: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 464: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 465: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 466: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 467: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 468: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 469: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 470: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 471: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 472: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 473: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 474: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 475: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 476: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 477: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 478: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 479: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 480: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 481: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 482: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 483: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 484: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 485: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 486: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 487: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 488: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 489: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 490: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 491: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 492: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 493: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 494: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 495: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 496: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 497: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 498: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 499: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 500: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 501: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 502: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 503: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 504: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 505: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 506: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 507: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 508: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 509: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 510: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 511: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 512: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 513: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 514: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 515: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 516: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 517: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 518: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 519: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 520: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 521: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 522: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 523: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 524: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 525: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 526: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 527: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 528: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 529: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 530: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 531: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 532: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 533: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 534: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 535: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 536: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 537: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 538: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 539: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 540: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 541: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 542: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 543: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 544: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 545: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 546: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 547: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 548: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 549: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 550: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 551: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 552: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 553: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 554: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 555: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 556: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 557: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 558: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 559: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 560: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 561: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 562: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 563: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 564: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 565: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 566: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 567: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 568: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 569: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 570: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 571: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 572: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 573: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 574: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 575: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 576: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 577: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 578: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 579: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 580: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 581: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 582: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 583: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 584: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 585: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 586: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 587: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 588: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 589: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 590: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 591: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 592: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 593: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 594: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 595: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 596: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 597: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 598: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 599: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 600: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 601: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 602: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 603: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 604: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 605: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 606: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 607: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 608: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 609: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 610: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 611: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 612: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 613: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 614: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 615: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 616: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 617: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 618: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 619: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 620: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 621: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 622: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 623: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 624: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 625: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 626: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 627: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 628: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 629: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 630: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 631: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 632: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 633: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 634: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 635: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 636: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 637: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 638: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 639: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 640: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 641: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 642: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 643: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 644: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 645: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 646: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 647: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 648: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 649: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 650: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 651: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 652: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 653: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 654: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 655: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 656: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 657: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 658: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 659: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 660: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 661: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 662: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 663: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 664: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 665: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 666: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 667: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 668: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 669: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 670: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 671: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 672: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 673: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 674: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 675: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 676: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 677: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 678: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 679: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 680: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 681: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 682: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 683: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 684: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 685: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 686: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 687: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 688: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 689: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 690: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 691: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 692: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 693: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 694: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 695: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 696: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 697: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 698: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 699: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 700: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 701: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 702: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 703: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 704: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 705: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 706: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 707: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 708: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 709: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 710: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 711: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 712: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 713: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 714: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 715: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 716: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 717: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 718: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 719: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 720: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 721: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 722: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 723: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 724: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 725: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 726: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 727: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 728: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 729: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 730: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 731: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 732: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 733: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 734: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 735: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 736: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 737: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 738: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 739: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 740: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 741: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 742: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 743: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 744: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 745: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 746: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 747: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 748: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 749: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 750: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 751: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 752: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 753: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 754: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 755: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 756: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 757: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 758: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 759: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 760: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 761: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 762: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 763: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 764: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 765: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 766: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 767: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 768: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 769: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 770: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 771: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 772: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 773: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 774: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 775: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 776: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 777: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 778: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 779: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 780: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 781: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 782: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 783: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 784: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 785: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 786: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 787: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 788: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 789: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 790: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 791: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 792: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 793: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 794: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 795: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 796: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 797: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 798: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 799: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 800: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 801: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 802: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 803: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 804: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 805: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 806: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 807: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 808: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 809: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 810: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 811: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 812: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 813: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 814: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 815: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 816: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 817: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 818: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 819: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 820: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 821: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 822: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 823: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 824: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 825: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 826: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 827: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 828: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 829: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 830: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 831: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 832: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 833: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 834: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 835: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 836: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 837: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 838: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 839: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 840: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 841: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 842: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 843: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 844: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 845: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 846: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 847: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 848: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 849: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 850: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 851: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 852: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 853: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 854: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 855: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 856: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 857: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 858: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 859: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 860: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 861: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 862: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 863: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 864: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 865: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 866: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 867: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 868: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 869: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 870: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 871: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 872: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 873: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 874: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 875: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 876: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 877: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 878: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 879: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 880: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 881: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 882: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 883: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 884: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 885: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 886: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 887: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 888: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 889: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 890: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 891: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 892: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 893: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 894: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 895: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 896: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 897: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 898: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 899: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 900: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 901: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 902: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 903: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 904: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 905: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 906: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 907: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 908: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 909: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 910: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 911: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 912: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 913: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 914: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 915: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 916: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 917: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 918: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 919: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 920: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 921: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 922: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 923: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 924: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 925: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 926: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 927: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 928: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 929: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 930: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 931: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 932: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 933: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 934: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 935: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 936: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 937: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 938: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 939: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 940: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 941: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 942: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 943: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 944: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 945: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 946: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 947: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 948: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 949: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 950: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 951: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 952: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 953: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 954: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 955: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 956: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 957: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 958: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 959: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 960: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 961: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 962: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 963: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 964: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 965: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 966: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 967: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 968: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 969: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 970: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 971: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 972: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 973: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 974: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 975: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 976: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 977: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 978: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 979: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 980: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 981: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 982: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 983: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 984: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 985: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 986: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 987: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 988: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 989: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 990: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 991: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 992: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 993: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 994: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 995: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 996: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 997: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 998: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 999: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic 1000: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm lobaplatin lcss asei
Topic Occurence Count:
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
Active topics:
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29]
Active topics in data:
[10, 10, 10, 10, 10, 10, 11, 10, 9, 9, 9, 9, 9, 9, 10, 10, 9, 9, 9, 9, 9, 9, 9, 10, 10, 10, 10, 10, 10, 9, 9, 9, 9, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 11, 11, 11, 12, 11, 11, 11, 11, 11, 11, 12, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 10, 11, 11, 11, 12, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 12, 12, 12, 13, 13, 12, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 14, 14, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 15, 15, 15, 15, 15, 15, 15, 15, 15, 14, 14, 14, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 14, 14, 14, 14, 15, 15, 15, 15, 16, 15, 15, 15, 15, 15, 15, 16, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 16, 15, 15, 15, 15, 15, 15, 15, 15, 15, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 17, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 15, 15, 15, 16, 16, 16, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 14, 15, 16, 16, 15, 15, 16, 16, 15, 15, 15, 16, 15, 15, 15, 15, 15, 16, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 14, 15, 14, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 16, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 14, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 16, 15, 15, 15, 15, 15, 15, 15, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 17, 17, 16, 16, 16, 15, 15, 15, 15, 15, 15, 15, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 17, 17, 17, 17, 17, 17, 17, 17, 17, 18, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 18, 17, 17, 17, 17, 17, 17, 16, 17, 17, 18, 18, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 18, 17, 17, 18, 19, 17, 17, 17, 18, 17, 17, 17, 17, 17, 17, 17, 17, 17, 18, 17, 17, 17, 17, 18, 17, 17, 17, 17, 17, 17, 17, 18, 18, 18, 18, 18, 18, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 18, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 18, 18, 18, 20, 19, 17, 18, 19, 18, 18, 18, 18, 18, 18, 17, 18, 18, 18, 18, 19, 19, 19, 19, 18, 19, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 20, 19, 19, 19, 19, 19, 19, 19, 19, 20, 19, 19, 20, 19, 19, 18, 18, 18, 18, 18, 18, 18, 17, 18, 18, 20, 19, 19, 19, 18, 18, 18, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 20, 18, 20, 19, 19, 18, 20, 19, 18, 18, 18, 18, 18, 18, 18, 18, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 19, 19, 20, 19, 19, 19, 19, 19, 19, 20, 20, 19, 19, 19, 19, 19, 20, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 18, 18, 18, 18, 19, 18, 18, 18, 18, 18, 18, 18, 19, 18, 18, 18, 19, 18, 18, 18, 18, 19, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 18, 18, 18, 18, 18, 18, 18, 18, 19, 18, 18, 18, 18, 18, 18, 19, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 17, 18, 18, 18, 18, 18, 19, 18, 18, 19, 18, 18, 18, 18, 18, 18, 19, 18, 18, 18, 18, 18, 18, 19, 19, 18, 19, 19, 19, 19, 19, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 18, 18, 19, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 18, 18, 19, 18, 19, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 20, 18, 18, 18, 19, 18, 18, 18, 19, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 20, 19, 19, 18, 18, 18, 18, 18, 18, 18, 18, 19, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 17, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 20, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 18, 19, 19, 18, 18, 18, 18, 18, 18, 18, 18, 20, 19, 19, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 20, 20, 19, 19, 19, 19, 19, 19, 18, 18, 18, 18, 18, 17, 18, 18, 18, 18, 19, 18, 18, 18, 18, 18, 17, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 20, 20, 19, 19, 19, 19, 18, 19, 19, 19, 19, 19, 19, 19, 19, 19, 18, 18, 18, 18, 18, 18, 18, 18, 19, 18, 18, 18, 18, 18, 19, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 19, 19, 18, 18, 19, 18, 19, 18, 18, 18, 18, 18, 18, 18, 18, 19, 18, 18, 18, 18, 17, 19, 19, 19, 19, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 18, 18, 19, 19, 19, 19, 19, 20, 20, 20, 20, 21, 20, 20, 20, 20, 20, 21, 20, 21, 22, 22, 23, 23, 22, 22, 22, 23, 22, 24, 23, 23, 23, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 23, 22, 22, 22, 22, 22, 22, 22, 22, 22, 23, 23, 23, 24, 24, 23, 23, 23, 23, 23, 22, 22, 22, 22, 22, 23, 22, 22, 23, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 23, 23, 22, 22, 22, 22, 22, 22, 23, 24, 23, 24, 24, 24, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 24, 24, 23, 22, 22, 22, 22, 22, 22, 22, 22, 22, 23, 22, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 25, 23, 23, 23, 22, 22, 22, 22, 22, 23, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 23, 22, 21, 22, 21, 21, 21, 22, 22, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 22, 22, 21, 22, 24, 23, 23, 23, 24, 23, 23, 23, 23, 23, 23, 24, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 22, 22, 22, 22, 22, 22, 22, 21, 21, 21, 21, 21, 21, 22, 22, 21, 20, 21, 21, 21, 21, 20, 22, 22, 21, 22, 21, 21, 21, 21, 21, 21, 22, 22, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 22, 22, 21, 22, 22, 22, 22, 22, 22, 21, 21, 22, 22, 21, 21, 21, 21, 21, 21, 23, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 23, 21, 21, 21, 20, 21, 22, 23, 22, 22, 21, 21, 21, 22, 22, 22, 22, 22, 22, 21, 21, 21, 21, 21, 21, 22, 23, 22, 22, 22, 22, 22, 23, 23, 22, 25, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 23, 23, 23, 24, 23, 23, 23, 23, 23, 23, 24, 23, 23, 23, 23, 23, 23, 23, 24, 23, 23, 24, 24, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 24, 23, 23, 23, 23, 23, 24, 24, 24, 24, 24, 24, 23, 23, 23, 24, 23, 23, 23, 23, 24, 23, 23, 24, 24, 23, 23, 23, 23, 24, 24, 26, 25, 24, 24, 24, 24, 24, 24, 24, 25, 24, 24, 24, 24, 25, 25, 25, 25, 25, 24, 24, 24, 24, 24, 24, 25, 25, 25, 26, 25, 26, 25, 25, 25, 25, 25, 25, 27, 26, 25, 26, 25, 25, 24, 22, 24, 24, 23, 23, 24, 23, 23, 23, 23, 23, 23, 24, 23, 23, 23, 23, 23, 23, 25, 24, 24, 23, 23, 24, 24, 23, 23, 23, 23, 24, 23, 23, 23, 25, 23, 23, 23, 23, 23, 24, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 22, 24, 25, 25, 26, 25, 25, 25, 25, 26, 26, 26, 25, 24, 24, 24, 24, 25, 25, 25, 25, 25, 25, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 25, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 25, 24, 24, 25, 24, 24, 24, 24, 24, 24, 23, 25, 23, 24, 23, 23, 23, 24, 24, 23, 23, 23, 24, 24, 23, 23, 23, 24, 24, 24, 23, 23, 22, 23, 23, 23, 23, 24, 23, 23, 23, 24, 23, 22, 23, 23, 23, 23, 24, 23, 23, 23, 24, 23, 23, 23, 23, 23, 23, 23, 25, 25, 25, 24, 24, 25, 23, 24, 24, 24, 24, 24, 24, 25, 24, 24, 24, 24, 26, 24, 24, 24, 24, 24, 23, 24, 24, 25, 24, 24, 23, 23, 24, 24, 23, 24, 23, 23, 24, 23, 23, 24, 24, 23, 24, 23, 24, 23, 23, 23, 23, 24, 24, 23, 23, 23, 23, 23, 23, 24, 25, 24, 24, 24, 24, 23, 23, 23, 23, 23, 23, 23, 24, 23, 23, 23, 24, 24, 23, 24, 23, 23, 23, 23, 23, 24, 23, 23, 24, 23, 23, 23, 23, 23, 23, 23, 24, 23, 24, 24, 24, 24, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 24, 23, 23, 23, 23, 23, 24, 24, 23, 23, 23, 23, 23, 23, 23, 23, 23, 24, 25, 24, 23, 22, 23, 24, 25, 23, 23, 24, 23, 23, 24, 23, 23, 23, 23, 23, 22, 23, 22, 22, 22, 22, 22, 22, 23, 22, 22, 22, 22, 22, 22, 22, 22, 23, 23, 22, 22, 22, 22, 22, 22, 22, 23, 23, 23, 23, 23, 24, 23, 23, 22, 23, 24, 23, 23, 24, 23, 23, 23, 23, 24, 23, 24, 23, 24, 23, 23, 23, 23, 23, 24, 25, 24, 24, 24, 25, 25, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 25, 24, 24, 23, 24, 24, 24, 24, 24, 24, 24, 24, 24, 25, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 25, 24, 24, 24, 24, 24, 24, 25, 24, 24, 24, 24, 24, 24, 24, 25, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 25, 24, 23, 24, 24, 24, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 24, 24, 23, 23, 23, 24, 24, 24, 23, 23, 23, 23, 23, 23, 23, 23, 23, 24, 23, 23, 24, 23, 23, 23, 23, 23, 23, 23, 24, 23, 22, 24, 24, 23, 23, 23, 23, 24, 24, 24, 24, 24, 24, 25, 24, 24, 24, 24, 24, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 24, 23, 23, 23, 23, 23, 24, 23, 23, 24, 23, 23, 23, 23, 23, 23, 24, 23, 24, 24, 24, 23, 23, 23, 23, 23, 24, 24, 23, 23, 23, 23, 23, 24, 23, 23, 23, 23, 23, 23, 24, 23, 23, 23, 24, 24, 24, 23, 23, 24, 23, 23, 23, 24, 23, 24, 24, 23, 23, 23, 24, 23, 24, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 24, 24, 24, 25, 23, 24, 23, 23, 23, 23, 23, 24, 24, 25, 25, 24, 23, 24, 24, 23, 23, 23, 23, 24, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 25, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 24, 24, 23, 23, 23, 23, 24, 23, 23, 23, 22, 23, 23, 24, 25, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 25, 24, 24, 24, 24, 24, 25, 25, 24, 24, 24, 25, 27, 25, 26, 25, 24, 24, 24, 24, 25, 24, 25, 25, 24, 26, 24, 24, 24, 25, 23, 23, 23, 23, 23, 23, 23, 23, 23, 24, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 24, 25, 24, 24, 25, 24, 26, 25, 24, 24, 24, 24, 24, 25, 26, 26, 26, 26, 25, 25, 25, 25, 25, 24, 24, 24, 24, 24, 24, 25, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 25, 26, 24, 25, 24, 24, 23, 25, 24, 24, 25, 24, 24, 26, 27, 27, 27, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 25, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 27, 27, 26, 25, 26, 27, 25, 25, 26, 25, 25, 25, 25, 25, 25, 25, 25, 26, 26, 25, 25, 25, 25, 25, 25, 25, 25, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 26, 26, 25, 25, 25, 25, 25, 25, 26, 26, 26, 25, 27, 25, 25, 25, 25, 25, 25, 25, 24, 24, 24, 25, 25, 25, 24, 24, 24, 25, 24, 24, 25, 24, 24, 24, 25, 24, 24, 25, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 25, 25, 25, 25, 26, 25, 25, 25, 25, 26, 26, 25, 25, 26, 26, 25, 25, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 26, 26, 25, 25, 26, 25, 26, 25, 25, 25, 25, 25, 25, 26, 26, 26, 25, 25, 25, 25, 25, 26, 25, 25, 25, 26, 26, 25, 25, 25, 25, 25, 25, 25, 26, 25, 25, 25, 26, 25, 25, 25, 25, 25, 25, 26, 26, 25, 25, 25, 25, 26, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 25, 26, 26, 26, 26, 26, 26, 27, 27, 27, 27, 27, 27, 27, 27, 28, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 26, 27, 27, 26, 26, 26, 26, 27, 26, 26, 27, 27, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 27, 26, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 25, 26, 26, 25, 25, 26, 25, 26, 25, 25, 25, 25, 26, 26, 25, 25, 25, 25, 25, 26, 25, 26, 25, 26, 26, 25, 25, 25, 25, 25, 25, 26, 25, 25, 25, 26, 25, 25, 26, 25, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 25, 26, 25, 26, 25, 26, 25, 25, 25, 25, 27, 26, 26, 26, 26, 26, 27, 26, 27, 27, 27, 27, 27, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 26, 26, 26, 25, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 26, 27, 28, 27, 27, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 25, 25, 25, 25, 26, 25, 25, 25, 25, 25, 26, 25, 25, 25, 25, 26, 25, 25, 25, 25, 25, 25, 24, 25, 25, 25, 25, 25, 27, 25, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 25, 25, 25, 26, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 25, 26, 26, 27, 27, 27, 26, 27, 27, 26, 27, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 27, 27, 26, 26, 26, 26, 26, 27, 27, 27, 26, 26, 26, 26, 26, 25, 26, 26, 27, 26, 26, 26, 28, 26, 26, 26, 26, 26, 26, 27, 26, 26, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 26, 27, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 25, 26, 26, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 27, 26, 26, 27, 28, 26, 26, 26, 26, 25, 26, 26, 26, 28, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 25, 25, 26, 26, 25, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 26, 26, 26, 27, 26, 25, 25, 25, 25, 25, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 25, 25, 25, 26, 25, 25, 25, 25, 25, 26, 26, 27, 27, 27, 26, 26, 27, 26, 27, 26, 26, 26, 27, 26, 27, 27, 27, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 27, 26, 27, 27, 27, 29, 27, 27, 27, 27, 27, 27, 28, 28, 28, 28, 27, 27, 26, 27, 28, 27, 27, 27, 27, 28, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 28, 27, 28, 28, 28, 28, 28, 27, 27, 27, 28, 27, 27, 27, 27, 27, 26, 26, 26, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 25, 25, 25, 26, 27, 25, 25, 26, 25, 25, 25, 25, 25, 25, 26, 26, 25, 25, 27, 25, 25, 25, 26, 26, 26, 25, 25, 26, 25, 25, 25, 25, 25, 25, 26, 26, 25, 25, 25, 25, 27, 25, 26, 25, 25, 25, 25, 25, 26, 25, 25, 25, 25, 26, 26, 25, 25, 26, 25, 25, 25, 25, 26, 25, 25, 26, 26, 25, 26, 25, 26, 25, 25, 27, 27, 28, 27, 27, 28, 26, 27, 26, 26, 26, 26, 26, 26, 28, 27, 27, 27, 27, 28, 27, 26, 27, 27, 27, 27, 27, 27, 27, 27, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 27, 27, 28, 27, 27, 27, 28, 27, 26, 27, 26, 27, 26, 27, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 27, 27, 28, 29, 28, 28, 28, 27, 27, 27, 27, 27, 28, 29, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 29, 28, 28, 28, 28, 29, 28, 29, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 29, 27, 27, 27, 27, 28, 27, 27, 26, 27, 28, 27, 27, 27, 28, 28, 27, 27, 27, 27, 27, 28, 27, 27, 28, 27, 28, 26, 28, 28, 28, 28, 27, 27, 27, 27, 27, 26, 27, 26, 27, 27, 27, 27, 27, 27, 27, 27, 27, 28, 27, 27, 27, 27, 27, 27, 28, 27, 27, 27, 27, 27, 27, 27, 28, 27, 27, 27, 28, 26, 27, 28, 28, 27, 28, 27, 27, 27, 27, 28, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 28, 28, 28, 27, 27, 27, 27, 28, 27, 27, 28, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 28, 27, 27, 27, 29, 28, 28, 28, 28, 27, 27, 27, 27, 27, 27, 27, 28, 27, 27, 27, 27, 27, 27, 27, 28, 27, 28, 28, 27, 27, 27, 27, 27, 27, 28, 28, 28, 28, 28, 28, 27, 28, 29, 27, 27, 27, 27, 27, 27, 28, 27, 27, 27, 27, 27, 28, 27, 27, 27, 27, 27, 27, 27, 27, 26, 27, 28, 27, 27, 27, 28, 28, 28, 28, 28, 27, 28, 28, 28, 27, 27, 29, 28, 27, 27, 27, 27, 27, 27, 28, 27, 27, 27, 27, 27, 27, 27, 27, 27, 28, 28, 28, 27, 27, 28, 27, 28, 28, 28, 28, 28, 28, 29, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 29, 29, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 30, 29, 29, 30, 29, 29, 29, 29, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 27, 28, 28, 28, 28, 28, 28, 28, 28, 30, 28, 29, 28, 29, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 30, 28, 28, 28, 28, 28, 29, 29, 29, 28, 28, 28, 28, 28, 29, 28, 28, 29, 31, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 30, 30, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 29, 29, 29, 29, 29, 30, 29, 28, 29, 28, 28, 28, 28, 28, 28, 28, 29, 29, 29, 29, 30, 29, 30, 29, 29, 30, 30, 29, 29, 29, 29, 30, 29, 28, 29, 30, 28, 28, 29, 28, 29, 28, 28, 28, 29, 29, 29, 29, 29, 29, 30, 28, 29, 28, 28, 29, 29, 29, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 29, 29, 29, 29, 30, 29, 30, 29, 29, 29, 29, 29, 30, 29, 30, 30, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 29, 31, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 28, 29, 30, 29, 29, 29, 30, 29, 29, 30, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 29, 30, 30, 30, 29, 30, 31, 31, 31, 30, 29, 31, 30, 31, 30, 30, 31, 30, 30, 30, 31, 30, 30, 30, 30, 30, 31, 30, 31, 31, 30, 31, 30, 30, 30, 30, 30, 30, 30, 31, 31, 30, 30, 30, 30, 30, 30, 30, 31, 31, 30, 31, 30, 30, 30, 30, 30, 30, 30, 31, 30, 30, 30, 31, 30, 30, 32, 30, 30, 31, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 32, 31, 30, 31, 31, 31, 31, 31, 31, 32, 32, 32, 32, 32, 32, 31, 32, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 33, 32, 32, 33, 33, 33, 33, 32, 31, 32, 31, 32, 31, 31, 31, 31, 32, 31, 31, 31, 31, 31, 31, 31, 31, 32, 32, 31, 31, 31, 33, 30, 31, 31, 32, 31, 31, 32, 32, 31, 31, 32, 31, 31, 31, 32, 31, 31, 31, 32, 31, 31, 31, 31, 31, 32, 31, 32, 32, 31, 31, 31, 30, 32, 33, 31, 31, 31, 31, 31, 31, 31, 31, 33, 32, 31, 32, 31, 31, 31, 32, 30, 32, 31, 31, 31, 32, 31, 31, 32, 31, 31, 31, 31, 32, 32, 31, 32, 31, 31, 32, 31, 31, 31, 31, 31, 32, 31, 32, 31, 31, 32, 32, 31, 31, 31, 31, 31, 31, 31, 31, 31, 32, 32, 32, 32, 32, 33, 33, 33, 33, 33, 33, 33, 34, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 33, 32, 32, 32, 33, 32, 32, 32, 33, 32, 34, 32, 32, 33, 33, 32, 32, 33, 32, 32, 32, 32, 32, 32, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 33, 32, 31, 32, 32, 32, 32, 32, 32, 31, 32, 32, 31, 33, 32, 31, 31, 31, 31, 31, 31, 30, 31, 31, 31, 32, 33, 31, 31, 31, 32, 31, 33, 32, 31, 31, 31, 31, 31, 31, 31, 32, 31, 31, 31, 32, 31, 31, 31, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 31, 32, 31, 31, 31, 31, 31, 31, 31, 32, 31, 31, 32, 31, 31, 31, 31, 31, 31, 31, 32, 32, 31, 31, 31, 31, 31, 31, 31, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 33, 32, 32, 33, 32, 32, 32, 33, 32, 32, 33, 33, 32, 32, 32, 32, 32, 32, 32, 34, 32, 33, 31, 33, 33, 33, 32, 33, 33, 32, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 34, 33, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 34, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 32, 34, 34, 35, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 34, 34, 34, 34, 33, 33, 32, 33, 33, 33, 34, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 34, 33, 34, 33, 33, 34, 33, 34, 33, 34, 32, 33, 33, 32, 34, 34, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 34, 33, 34, 33, 32, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 32, 33, 33, 32, 33, 34, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 34, 34, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 34, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 32, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 34, 34, 34, 33, 33, 33, 34, 33, 33, 34, 33, 33, 34, 33, 33, 33, 33, 32, 33, 34, 33, 34, 33, 33, 33, 33, 33, 33, 32, 33, 33, 33, 33, 35, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 35, 33, 33, 33, 33, 33, 34, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 34, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 33, 32, 33, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 34, 33, 33, 33, 34, 33, 34, 33, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 34, 33, 33, 33, 34, 33, 34, 33, 33, 33, 33, 34, 34, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 34, 33, 34, 33, 33, 33, 33, 33, 33, 33, 33, 32, 35, 33, 34, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 33, 32, 33, 34, 34, 34, 34, 33, 33, 32, 33, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 35, 33, 34, 33, 33, 33, 33, 33, 34, 33, 33, 33, 34, 33, 33, 33, 33, 34, 34, 34, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 32, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 32, 33, 33, 33, 33, 33, 33, 33, 32, 32, 33, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 33, 33, 33, 33, 33, 33, 33, 32, 33, 33, 34, 34, 34, 33, 33, 33, 33, 34, 33, 33, 33, 34, 33, 33, 34, 32, 33, 33, 33, 33, 33, 34, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 34, 34, 33, 34, 33, 33, 33, 33, 33, 33, 33, 34, 34, 33, 33, 34, 34, 33, 33, 33, 34, 32, 32, 32, 32, 32, 32, 32, 33, 32, 33, 32, 32, 32, 32, 32, 32, 31, 32, 32, 32, 32, 32, 32, 32, 32, 34, 34, 34, 33, 33, 32, 32, 33, 32, 32, 33, 32, 32, 32, 32, 32, 33, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 31, 33, 32, 32, 32, 32, 32, 32, 34, 33, 33, 33, 34, 33, 34, 33, 33, 34, 32, 32, 32, 33, 32, 32, 33, 33, 33, 33, 32, 34, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 31, 32, 32, 32, 33, 32, 32, 33, 32, 32, 32, 32, 32, 34, 33, 34, 32, 33, 33, 34, 33, 32, 33, 32, 32, 32, 32, 34, 33, 32, 32, 32, 32, 32, 34, 34, 33, 34, 36, 34, 34, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 32, 32, 32, 32, 33, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 33, 34, 33, 33, 33, 33, 33, 33, 32, 32, 32, 33, 33, 33, 32, 32, 32, 32, 32, 32, 33, 34, 33, 32, 33, 32, 32, 32, 34, 32, 31, 32, 32, 32, 32, 33, 32, 32, 32, 33, 32, 31, 31, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 33, 32, 33, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 33, 33, 33, 32, 33, 32, 32, 32, 33, 33, 33, 34, 33, 33, 32, 33, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 32, 31, 32, 32, 32, 32, 33, 32, 32, 32, 33, 33, 33, 32, 32, 32, 33, 33, 33, 33, 33, 33, 32, 32, 32, 32, 33, 32, 31, 32, 33, 32, 32, 32, 34, 32, 32, 32, 33, 32, 33, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 34, 33, 32, 32, 32, 32, 34, 33, 33, 33, 34, 33, 33, 33, 33, 34, 34, 36, 35, 35, 33, 34, 34, 34, 34, 34, 34, 34, 34, 34, 33, 34, 35, 34, 35, 34, 34, 35, 35, 34, 34, 34, 35, 34, 34, 34, 34, 34, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 36, 35, 36, 36, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 36, 36, 36, 37, 36, 36, 36, 36, 36, 38, 36, 36, 36, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 36, 35, 35, 35, 37, 35, 35, 35, 35, 36, 36, 35, 36, 35, 35, 35, 35, 34, 35, 35, 35, 36, 36, 35, 35, 35, 35, 36, 35, 35, 36, 35, 35, 35, 35, 35, 36, 35, 35, 35, 36, 35, 35, 35, 35, 35, 36, 36, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 33, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 34, 33, 33, 33, 33, 34, 32, 33, 33, 33, 34, 33, 35, 33, 33, 34, 33, 33, 33, 33, 33, 32, 33, 33, 34, 33, 33, 32, 33, 33, 34, 33, 33, 33, 34, 34, 33, 33, 34, 35, 34, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 34, 34, 34, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 32, 34, 34, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 34, 34, 33, 33, 34, 35, 35, 34, 34, 34, 32, 34, 33, 33, 33, 33, 33, 33, 34, 35, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 34, 34, 33, 34, 34, 34, 34, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 36, 39, 37, 36, 36, 36, 36, 36, 36, 35, 36, 36, 36, 36, 36, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 33, 34, 35, 35, 34, 34, 35, 35, 35, 34, 34, 34, 34, 34, 35, 35, 35, 34, 34, 35, 34, 36, 34, 34, 34, 34, 35, 34, 35, 36, 35, 34, 34, 34, 34, 34, 34, 35, 35, 36, 35, 35, 35, 35, 36, 36, 35, 35, 35, 35, 36, 36, 36, 35, 36, 35, 35, 35, 35, 36, 36, 36, 36, 37, 36, 36, 36, 36, 37, 36, 36, 36, 36, 36, 37, 35, 37, 34, 35, 36, 36, 35, 35, 35, 35, 36, 35, 35, 36, 35, 36, 35, 35, 35, 35, 35, 36, 36, 36, 36, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 36, 35, 35, 36, 36, 36, 36, 36, 36, 37, 36, 35, 36, 36, 36, 36, 36, 36, 36, 36, 35, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 37, 37, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 37, 37, 37, 37, 37, 37, 38, 39, 37, 38, 37, 37, 37, 37, 37, 36, 36, 37, 37, 37, 37, 37, 37, 36, 36, 37, 37, 37, 37, 37, 37, 36, 37, 37, 37, 39, 37, 37, 37, 36, 37, 37, 37, 37, 37, 38, 38, 38, 37, 38, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 36, 37, 38, 37, 37, 37, 38, 37, 37, 38, 37, 37, 38, 38, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 37, 37, 37, 37, 37, 38, 38, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 36, 37, 37, 37, 37, 37, 38, 38, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 38, 37, 37, 36, 37, 37, 37, 37, 37, 37, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 37, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 37, 38, 37, 37, 37, 37, 37, 38, 38, 38, 38, 38, 38, 38, 37, 37, 37, 37, 37, 36, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 38, 36, 38, 37, 37, 38, 37, 37, 37, 37, 37, 37, 38, 38, 37, 37, 39, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 38, 38, 38, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 39, 38, 39, 36, 37, 37, 38, 37, 37, 37, 37, 38, 37, 36, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 36, 37, 38, 37, 37, 36, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 39, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 38, 37, 37, 37, 37, 38, 38, 38, 37, 37, 37, 38, 39, 38, 37, 37, 37, 37, 37, 37, 38, 37, 38, 37, 38, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 38, 37, 37, 38, 38, 36, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 36, 38, 37, 37, 36, 37, 38, 38, 37, 37, 38, 37, 37, 37, 37, 37, 38, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 36, 37, 37, 37, 37, 37, 39, 38, 38, 40, 38, 37, 38, 39, 38, 38, 38, 37, 38, 37, 37, 38, 37, 37, 37, 37, 37, 40, 37, 37, 37, 38, 36, 37, 37, 38, 38, 37, 37, 37, 37, 37, 38, 38, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 39, 39, 37, 37, 37, 37, 37, 37, 36, 38, 39, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 40, 40, 39, 39, 40, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 38, 40, 40, 39, 39, 39, 39, 39, 39, 39, 40, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 39, 38, 38, 38, 38, 38, 37, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 37, 37, 38, 37, 37, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 36, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 36, 37, 38, 36, 37, 37, 38, 38, 37, 37, 37, 38, 38, 37, 38, 37, 37, 37, 37, 38, 37, 37, 37, 37, 38, 39, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 38, 37, 37, 37, 39, 37, 38, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 36, 37, 37, 38, 37, 37, 37, 37, 38, 37, 37, 38, 37, 36, 38, 39, 38, 38, 38, 38, 39, 38, 38, 38, 38, 39, 40, 38, 39, 38, 38, 38, 39, 38, 38, 39, 39, 39, 38, 38, 39, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 40, 38, 39, 37, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 37, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 37, 40, 38, 38, 38, 38, 39, 38, 39, 38, 38, 38, 39, 39, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 38, 38, 38, 37, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 39, 38, 37, 37, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 37, 38, 39, 38, 38, 38, 38, 38, 39, 38, 37, 38, 38, 38, 38, 38, 39, 38, 38, 39, 38, 38, 38, 38, 38, 39, 39, 42, 41, 39, 41, 39, 40, 40, 39, 39, 38, 39, 39, 39, 39, 39, 38, 40, 40, 40, 39, 39, 39, 39, 39, 39, 39, 39, 38, 38, 39, 38, 38, 38, 39, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 39, 39, 37, 38, 38, 38, 38, 38, 38, 38, 37, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 39, 38, 38, 39, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 39, 38, 38, 38, 37, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 39, 38, 38, 38, 38, 37, 38, 39, 38, 38, 38, 38, 40, 39, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 38, 38, 38, 38, 39, 40, 38, 38, 38, 38, 39, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 37, 38, 38, 38, 38, 37, 38, 38, 38, 38, 39, 38, 39, 40, 39, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 39, 38, 39, 38, 38, 38, 39, 39, 38, 39, 38, 39, 39, 38, 38, 38, 38, 39, 38, 38, 38, 38, 39, 39, 38, 38, 38, 38, 39, 38, 38, 38, 39, 38, 38, 39, 39, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 39, 38, 39, 39, 39, 38, 38, 38, 38, 38, 40, 38, 38, 38, 39, 39, 37, 38, 38, 38, 39, 38, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 39, 38, 38, 38, 38, 37, 38, 38, 38, 39, 39, 40, 40, 39, 39, 39, 39, 40, 39, 40, 39, 40, 39, 39, 39, 39, 39, 40, 40, 39, 39, 39, 38, 38, 38, 39, 39, 38, 38, 38, 38, 39, 39, 38, 38, 38, 38, 39, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 40, 38, 37, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 39, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 40, 40, 38, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 38, 38, 38, 39, 39, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 39, 39, 38, 38, 38, 39, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 39, 38, 38, 38, 39, 39, 39, 38, 39, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 37, 38, 38, 38, 38, 38, 39, 38, 38, 39, 39, 38, 38, 38, 37, 38, 38, 39, 38, 38, 39, 39, 38, 37, 38, 39, 38, 39, 39, 40, 39, 39, 38, 38, 38, 39, 38, 38, 38, 38, 39, 39, 38, 38, 39, 39, 39, 40, 39, 39, 39, 39, 39, 38, 38, 38, 38, 38, 38, 38, 39, 39, 39, 39, 37, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 37, 38, 37, 39, 38, 37, 38, 38, 39, 38, 38, 38, 38, 38, 38, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 37, 39, 38, 38, 39, 37, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 38, 39, 39, 40, 38, 40, 40, 40, 40, 41, 40, 40, 40, 40, 41, 41, 40, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 39, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 39, 39, 39, 38, 38, 37, 38, 40, 39, 39, 39, 39, 39, 39, 39, 39, 41, 39, 38, 39, 39, 39, 39, 39, 39, 39, 39, 38, 38, 38, 38, 38, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 39, 39, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 37, 38, 38, 38, 39, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 37, 38, 39, 37, 38, 38, 38, 38, 38, 38, 39, 38, 39, 39, 38, 38, 40, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 37, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 37, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 37, 38, 39, 38, 38, 39, 38, 39, 37, 38, 38, 38, 38, 38, 37, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 37, 38, 38, 38, 39, 37, 40, 38, 37, 38, 38, 38, 38, 38, 38, 37, 38, 38, 38, 39, 39, 38, 38, 38, 38, 39, 39, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 39, 39, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 39, 38, 38, 39, 38, 38, 38, 39, 39, 38, 38, 37, 38, 38, 37, 39, 39, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 39, 38, 38, 38, 39, 39, 39, 39, 39, 40, 39, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 39, 38, 38, 38, 39, 38, 39, 38, 38, 38, 39, 38, 38, 38, 38, 38, 39, 38, 39, 38, 41, 38, 38, 39, 39, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 37, 39, 38, 38, 39, 38, 40, 39, 38, 39, 38, 38, 38, 38, 38, 39, 38, 39, 38, 39, 39, 38, 38, 38, 39, 39, 39, 38, 38, 38, 38, 39, 39, 37, 38, 38, 38, 38, 38, 38, 38, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 37, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 40, 38, 37, 38, 38, 38, 38, 38, 38, 38, 39, 38, 39, 38, 38, 38, 38, 37, 38, 38, 38, 38, 38, 38, 39, 38, 39, 39, 38, 38, 38, 38, 38, 38, 39, 38, 38, 39, 38, 38, 39, 39, 40, 39, 38, 38, 38, 39, 39, 38, 38, 38, 38, 38, 37, 37, 39, 37, 37, 37, 38, 37, 39, 37, 38, 38, 38, 38, 37, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 39, 40, 40, 37, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 41, 39, 39, 38, 40, 39, 39, 39, 39, 39, 40, 39, 41, 39, 40, 39, 39, 40, 40, 40, 40, 41, 40, 40, 40, 40, 41, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 41, 40, 40, 40, 40, 39, 39, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 42, 39, 40, 40, 40, 40, 40, 40, 40, 40, 40, 39, 40, 39, 39, 40, 39, 39, 39, 39, 39, 40, 38, 39, 39, 39, 39, 39, 38, 40, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 38, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 41, 39, 39, 39, 39, 39, 39, 39, 38, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 38, 39, 40, 39, 40, 40, 40, 39, 39, 40, 39, 40, 40, 40, 39, 40, 40, 40, 40, 40, 40, 41, 41, 40, 40, 40, 40, 40, 40, 40, 40, 39, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 41, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 41, 40, 39, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 41, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 39, 40, 39, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 40, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 40, 39, 40, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 38, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 40, 39, 39, 39, 39, 40, 40, 40, 39, 40, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 40, 41, 40, 39, 40, 40, 40, 40, 39, 39, 39, 38, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 40, 40, 41, 40, 40, 39, 39, 39, 39, 39, 39, 40, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 38, 40, 40, 39, 39, 39, 39, 39, 40, 39, 40, 38, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 40, 40, 40, 40, 39, 39, 38, 39, 39, 39, 39, 38, 39, 39, 39, 40, 39, 40, 40, 39, 39, 39, 39, 41, 41, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 39, 40, 40, 40, 40, 40, 40, 40, 40, 39, 40, 40, 40, 40, 41, 40, 41, 41, 40, 41, 41, 41, 42, 40, 40, 40, 40, 40, 41, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 42, 43, 43, 43, 43, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 43, 42, 42, 42, 41, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 41, 42, 42, 42, 43, 42, 42, 41, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 41, 41, 41, 41, 41, 41, 41, 40, 41, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 41, 40, 41, 40, 40, 40, 40, 40, 40, 40, 42, 40, 40, 40, 41, 41, 40, 40, 40, 40, 40, 41, 41, 41, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 42, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 41, 40, 40, 41, 39, 40, 40, 39, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 41, 40, 40, 40, 40, 42, 40, 40, 40, 40, 40, 39, 40, 39, 40, 40, 40, 40, 40, 40, 40, 39, 40, 40, 39, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 41, 41, 41, 42, 40, 41, 41, 40, 41, 40, 41, 41, 41, 41, 41, 41, 41, 41, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 39, 40, 41, 40, 40, 41, 40, 41, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 39, 40, 40, 41, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 39, 40, 40, 41, 41, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 42, 40, 40, 40, 40, 40, 39, 40, 40, 40, 40, 40, 41, 40, 40, 41, 40, 40, 40, 39, 40, 40, 40, 41, 40, 40, 40, 40, 40, 39, 42, 39, 41, 40, 39, 39, 40, 39, 39, 39, 39, 39, 39, 40, 40, 38, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 40, 39, 40, 40, 40, 40, 40, 39, 40, 39, 39, 40, 39, 39, 39, 39, 39, 38, 39, 39, 40, 40, 39, 40, 39, 39, 39, 38, 39, 39, 39, 39, 39, 38, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 41, 39, 39, 39, 39, 40, 40, 39, 39, 39, 39, 39, 38, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 38, 39, 39, 39, 40, 39, 39, 39, 40, 39, 39, 39, 39, 39, 40, 39, 39, 39, 40, 39, 39, 40, 39, 39, 39, 40, 40, 39, 39, 39, 40, 39, 39, 39, 39, 40, 39, 40, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 38, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 40, 38, 40, 40, 39, 39, 40, 40, 39, 39, 39, 39, 39, 39, 40, 41, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 40, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 38, 39, 38, 39, 39, 39, 39, 39, 38, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 38, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 40, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 40, 39, 39, 39, 40, 39, 40, 39, 39, 39, 39, 40, 39, 40, 39, 40, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 40, 39, 38, 39, 39, 39, 39, 39, 39, 39, 39, 38, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 40, 39, 40, 39, 39, 39, 39, 39, 40, 40, 40, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 40, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 38, 39, 39, 40, 39, 39, 39, 40, 39, 40, 39, 39, 40, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 40, 40, 39, 40, 39, 39, 40, 39, 38, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 38, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 38, 39, 39, 39, 40, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 38, 40, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 40, 39, 39, 40, 38, 39, 39, 40, 39, 39, 39, 40, 39, 39, 39, 38, 39, 40, 39, 39, 39, 40, 39, 40, 41, 40, 40, 40, 40, 39, 39, 39, 38, 39, 39, 40, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 38, 39, 38, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 38, 39, 39, 40, 39, 39, 39, 39, 39, 38, 39, 39, 39, 39, 39, 40, 39, 39, 40, 39, 40, 39, 39, 39, 39, 39, 39, 39, 40, 39, 40, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 38, 39, 38, 39, 41, 38, 39, 39, 39, 40, 41, 39, 39, 40, 40, 40, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 40, 39, 39, 39, 38, 39, 40, 39, 39, 39, 39, 40, 39, 39, 38, 40, 40, 39, 39, 39, 39, 39, 39, 40, 39, 39, 40, 40, 41, 40, 40, 39, 39, 41, 39, 39, 39, 39, 40, 39, 39, 39, 39, 40, 39, 39, 39, 38, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 41, 39, 39, 40, 39, 39, 40, 39, 40, 40, 39, 40, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 38, 40, 39, 39, 39, 39, 39, 39, 39, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 41, 40, 40, 40, 40, 40, 42, 40, 40, 39, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 39, 40, 41, 40, 40, 40, 40, 40, 40, 40, 41, 41, 41, 40, 40, 41, 40, 41, 41, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 41, 39, 40, 40, 40, 41, 41, 40, 40, 40, 40, 40, 40, 41, 40, 40, 41, 40, 40, 39, 40, 40, 40, 40, 40, 40, 41, 41, 41, 41, 40, 40, 41, 41, 40, 40, 40, 40, 41, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 41, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 41, 41, 42, 41, 41, 41, 41, 42, 41, 40, 40, 42, 40, 40, 40, 40, 41, 40, 40, 40, 41, 40, 40, 40, 40, 39, 40, 40, 40, 40, 42, 41, 40, 40, 40, 41, 40, 40, 40, 41, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 39, 39, 40, 39, 39, 39, 39, 39, 39, 40, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 40, 39, 39, 39, 39, 40, 39, 40, 40, 40, 39, 39, 40, 40, 41, 40, 39, 39, 39, 41, 39, 40, 40, 39, 40, 39, 39, 39, 39, 41, 40, 39, 40, 39, 38, 39, 39, 40, 40, 40, 39, 39, 39, 39, 39, 39, 38, 39, 39, 39, 40, 39, 39, 39, 38, 39, 38, 39, 40, 39, 39, 39, 40, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 40, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 38, 40, 39, 39, 39, 40, 39, 41, 40, 40, 39, 41, 39, 39, 39, 39, 39, 39, 39, 40, 38, 39, 40, 39, 39, 39, 40, 39, 39, 39, 39, 40, 40, 39, 38, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 41, 42, 40, 41, 41, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 41, 41, 41, 42, 40, 42, 41, 40, 40, 39, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 41, 40, 39, 40, 40, 41, 40, 40, 40, 39, 40, 40, 40, 40, 41, 41, 40, 40, 40, 39, 40, 40, 40, 40, 40, 40, 41, 41, 40, 40, 40, 41, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 42, 41, 40, 40, 40, 40, 40, 41, 40, 40, 41, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 39, 41, 39, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 41, 40, 41, 41, 41, 40, 39, 40, 40, 40, 40, 40, 40, 40, 40, 42, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 41, 42, 40, 40, 40, 40, 39, 40, 40, 41, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 42, 42, 40, 40, 40, 40, 41, 41, 40, 40, 41, 40, 40, 40, 41, 40, 42, 40, 39, 40, 40, 39, 40, 40, 41, 41, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 40, 39, 39, 39, 39, 39, 40, 40, 40, 39, 39, 39, 39, 40, 39, 39, 39, 38, 38, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 40, 40, 39, 40, 40, 40, 39, 39, 39, 39, 39, 40, 39, 40, 39, 39, 40, 40, 39, 39, 41, 39, 39, 39, 39, 38, 39, 38, 39, 39, 40, 39, 39, 39, 38, 39, 39, 40, 40, 39, 40, 43, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 42, 41, 41, 41, 41, 41, 42, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 42, 42, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 42, 41, 40, 40, 40, 40, 40, 41, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 41, 41, 41, 40, 40, 40, 40, 40, 41, 40, 41, 41, 40, 40, 41, 40, 40, 40, 41, 41, 41, 41, 42, 43, 42, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 42, 41, 42, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 42, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 40, 41, 41, 42, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 42, 41, 43, 42, 42, 41, 41, 41, 41, 42, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 40, 41, 41, 40, 41, 41, 41, 41, 41, 40, 42, 41, 41, 41, 41, 42, 42, 42, 41, 41, 42, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 40, 41, 41, 41, 42, 43, 41, 41, 40, 41, 41, 41, 41, 43, 42, 42, 43, 42, 43, 42, 42, 41, 41, 41, 41, 41, 41, 43, 42, 42, 42, 42, 44, 43, 43, 42, 42, 41, 42, 42, 42, 43, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 43, 43, 43, 42, 42, 42, 42, 42, 42, 44, 43, 42, 42, 42, 43, 42, 42, 42, 42, 43, 42, 42, 43, 41, 42, 42, 42, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 40, 41, 41, 41, 41, 42, 42, 42, 42, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 42, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 41, 40, 40, 40, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 42, 41, 42, 41, 41, 41, 41, 41, 42, 42, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 42, 42, 41, 41, 41, 41, 41, 43, 41, 41, 41, 41, 41, 41, 42, 41, 41, 40, 40, 42, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 40, 40, 41, 41, 41, 42, 41, 41, 41, 42, 41, 41, 41, 41, 41, 42, 41, 41, 42, 41, 41, 43, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 40, 40, 40, 40, 41, 40, 41, 40, 40, 41, 41, 42, 41, 40, 40, 39, 40, 41, 40, 40, 40, 41, 40, 40, 41, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 42, 40, 40, 41, 40, 40, 40, 41, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 41, 41, 42, 42, 41, 41, 42, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 42, 42, 41, 41, 41, 41, 41, 41, 42, 41, 42, 41, 41, 40, 41, 42, 42, 42, 43, 40, 41, 42, 41, 41, 41, 42, 42, 42, 41, 41, 41, 41, 41, 44, 41, 41, 41, 40, 41, 43, 41, 42, 41, 41, 41, 42, 41, 44, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 42, 43, 41, 41, 41, 41, 41, 42, 43, 42, 42, 42, 41, 41, 42, 41, 43, 41, 40, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 42, 41, 40, 40, 40, 40, 40, 41, 40, 40, 40, 41, 40, 40, 40, 39, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 42, 40, 41, 39, 41, 41, 40, 41, 40, 40, 40, 40, 41, 42, 41, 41, 41, 41, 41, 41, 41, 42, 42, 41, 41, 41, 42, 41, 41, 41, 42, 42, 42, 41, 41, 41, 41, 41, 42, 41, 41, 40, 42, 41, 40, 41, 42, 42, 41, 42, 42, 42, 43, 42, 42, 43, 42, 42, 42, 42, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 43, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 42, 41, 42, 42, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 42, 41, 41, 42, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 42, 41, 42, 42, 41, 41, 41, 41, 41, 41, 41, 42, 41, 42, 41, 41, 42, 42, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 42, 41, 43, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 42, 40, 41, 41, 41, 41, 42, 41, 41, 41, 42, 42, 41, 41, 41, 41, 41, 41, 41, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 41, 40, 41, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 43, 40, 40, 40, 41, 40, 40, 40, 42, 41, 40, 40, 41, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 41, 40, 40, 40, 41, 39, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 41, 40, 40, 41, 40, 40, 41, 40, 40, 40, 40, 41, 41, 41, 39, 42, 40, 40, 39, 40, 41, 40, 42, 41, 41, 40, 39, 40, 40, 40, 40, 41, 41, 40, 40, 40, 40, 40, 40, 42, 41, 41, 41, 40, 39, 40, 40, 40, 40, 43, 42, 42, 41, 41, 41, 42, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 42, 41, 41, 41, 41, 41, 42, 42, 41, 41, 41, 41, 41, 42, 41, 41, 40, 41, 41, 41, 41, 41, 42, 42, 42, 42, 41, 41, 41, 41, 41, 41, 40, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 42, 41, 40, 40, 40, 40, 41, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 41, 41, 42, 41, 40, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 40, 40, 40, 40, 40, 40, 40, 40, 41, 39, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 39, 40, 41, 40, 41, 40, 40, 40, 40, 41, 40, 41, 42, 42, 41, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 41, 41, 40, 40, 41, 41, 40, 39, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 39, 40, 40, 40, 40, 40, 41, 41, 40, 40, 40, 40, 40, 40, 40, 40, 39, 40, 41, 42, 41, 41, 40, 41, 41, 41, 40, 41, 41, 41, 40, 41, 39, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 39, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 41, 41, 41, 42, 41, 41, 41, 43, 41, 41, 42, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 40, 42, 42, 41, 41, 41, 41, 42, 41, 42, 41, 41, 41, 42, 40, 41, 41, 41, 41, 41, 41, 41, 40, 41, 41, 41, 41, 43, 42, 42, 42, 42, 42, 43, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 43, 42, 42, 42, 41, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 43, 42, 42, 42, 41, 42, 42, 42, 42, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 42, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 42, 41, 41, 42, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 42, 42, 41, 41, 41, 40, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 40, 41, 41, 43, 41, 41, 41, 41, 41, 41, 41, 42, 42, 42, 42, 41, 42, 42, 42, 42, 42, 43, 42, 42, 42, 43, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 41, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 41, 42, 42, 42, 41, 42, 42, 42, 42, 42, 42, 42, 43, 43, 43, 44, 45, 44, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 43, 44, 43, 43, 42, 42, 42, 42, 41, 42, 43, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 43, 43, 43, 43, 43, 42, 43, 43, 43, 44, 43, 43, 43, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 41, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 43, 42, 43, 42, 42, 42, 42, 42, 41, 41, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 42, 43, 44, 43, 44, 43, 43, 44, 44, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 42, 42, 42, 42, 42, 43, 43, 43, 42, 43, 44, 43, 43, 42, 44, 43, 43, 44, 43, 43, 43, 43, 42, 41, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 43, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 43, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 41, 42, 42, 41, 42, 42, 42, 43, 42, 43, 42, 43, 42, 43, 42, 42, 42, 42, 43, 42, 43, 44, 43, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 43, 42, 42, 42, 42, 41, 42, 42, 43, 42, 43, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 41, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 41, 43, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 42, 41, 41, 42, 42, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 42, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 43, 42, 42, 41, 41, 43, 43, 43, 42, 42, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 42, 42, 41, 42, 42, 43, 42, 41, 41, 41, 41, 43, 41, 41, 43, 41, 42, 41, 42, 42, 41, 41, 42, 42, 41, 41, 41, 41, 41, 41, 42, 42, 43, 43, 41, 41, 41, 41, 41, 42, 42, 41, 41, 41, 41, 42, 42, 42, 41, 41, 43, 41, 41, 42, 41, 40, 41, 41, 41, 41, 42, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 42, 41, 41, 42, 41, 41, 41, 41, 42, 42, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 42, 42, 42, 42, 43, 42, 42, 41, 41, 40, 42, 42, 41, 41, 42, 42, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 42, 41, 41, 42, 41, 41, 41, 42, 41, 41, 41, 42, 42, 41, 40, 41, 41, 41, 41, 42, 42, 41, 42, 43, 42, 41, 41, 41, 41, 41, 41, 41, 42, 42, 42, 42, 42, 41, 42, 42, 41, 41, 41, 41, 41, 42, 41, 42, 41, 41, 42, 41, 40, 41, 41, 42, 41, 41, 42, 41, 41, 41, 42, 41, 42, 41, 41, 42, 41, 41, 41, 41, 41, 41, 42, 42, 43, 43, 43, 44, 43, 43, 42, 42, 42, 42, 43, 42, 42, 43, 43, 42, 42, 43, 43, 42, 42, 42, 42, 42, 42, 42, 41, 42, 43, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 43, 42, 42, 42, 43, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 41, 42, 45, 43, 42, 42, 42, 42, 42, 42, 42, 42, 41, 41, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 41, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 44, 42, 42, 43, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 43, 42, 44, 43, 44, 42, 42, 42, 42, 42, 43, 43, 42, 42, 42, 42, 42, 42, 42, 41, 42, 41, 42, 42, 43, 42, 42, 43, 43, 43, 43, 42, 42, 42, 42, 42, 43, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 41, 42, 42, 43, 42, 43, 43, 43, 43, 42, 42, 41, 42, 43, 42, 43, 43, 43, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 43, 43, 42, 42, 41, 41, 42, 42, 42, 42, 42, 42, 44, 43, 43, 42, 42, 42, 42, 42, 43, 43, 42, 42, 42, 43, 43, 43, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 44, 43, 43, 42, 44, 42, 42, 42, 43, 42, 42, 42, 43, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 41, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 43, 42, 41, 42, 43, 43, 43, 42, 42, 44, 43, 44, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 43, 42, 43, 42, 42, 42, 42, 42, 42, 43, 42, 43, 43, 43, 42, 42, 43, 43, 43, 43, 43, 42, 42, 43, 44, 42, 42, 42, 42, 43, 42, 42, 44, 42, 42, 42, 43, 43, 43, 42, 42, 43, 42, 42, 42, 43, 43, 43, 43, 44, 43, 43, 43, 43, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 43, 43, 42, 42, 41, 43, 42, 42, 42, 42, 42, 42, 42, 41, 42, 44, 43, 43, 43, 43, 43, 43, 43, 43, 43, 42, 43, 43, 43, 42, 43, 43, 42, 42, 43, 44, 43, 43, 43, 43, 43, 43, 43, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 43, 43, 42, 42, 42, 42, 44, 42, 42, 42, 42, 42, 42, 42, 42, 42, 44, 43, 43, 43, 43, 43, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 43, 42, 42, 42, 43, 42, 42, 42, 43, 42, 43, 43, 42, 42, 43, 43, 44, 42, 42, 42, 43, 42, 41, 42, 43, 43, 42, 42, 42, 42, 44, 44, 43, 42, 42, 42, 42, 43, 43, 42, 43, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 43, 43, 42, 42, 41, 43, 43, 42, 42, 43, 42, 42, 42, 42, 41, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 44, 43, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 44, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 43, 42, 42, 42, 44, 43, 42, 42, 43, 42, 43, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 41, 44, 42, 43, 43, 42, 42, 42, 43, 43, 42, 42, 42, 42, 43, 42, 43, 43, 43, 43, 43, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 43, 42, 42, 42, 43, 42, 42, 42, 43, 42, 42, 42, 43, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 43, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 43, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 44, 43, 43, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 41, 41, 43, 42, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 40, 41, 41, 41, 41, 41, 42, 41, 41, 41, 42, 40, 42, 41, 41, 41, 42, 41, 42, 41, 41, 40, 42, 42, 42, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 42, 41, 42, 41, 41, 41, 41, 41, 42, 43, 43, 42, 42, 42, 42, 44, 43, 42, 42, 42, 42, 42, 42, 42, 41, 42, 41, 42, 43, 43, 42, 42, 42, 42, 43, 43, 42, 44, 43, 43, 43, 42, 42, 42, 42, 42, 41, 41, 43, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 42, 42, 42, 42, 41, 41, 42, 42, 41, 41, 41, 41, 41, 41, 42, 42, 41, 41, 41, 43, 42, 42, 42, 42, 42, 42, 42, 43, 42, 43, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 43, 42, 41, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 41, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 41, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 43, 43, 42, 42, 42, 43, 43, 42, 42, 42, 41, 42, 43, 42, 42, 42, 42, 42, 42, 42, 41, 43, 43, 42, 42, 42, 42, 42, 43, 43, 42, 42, 42, 42, 42, 43, 44, 43, 42, 44, 43, 42, 42, 42, 43, 43, 42, 42, 42, 42, 43, 43, 43, 42, 42, 42, 44, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 41, 42, 42, 43, 42, 42, 42, 43, 43, 43, 42, 43, 43, 43, 44, 44, 43, 43, 42, 43, 44, 44, 43, 44, 44, 42, 44, 44, 43, 43, 43, 44, 44, 43, 43, 43, 43, 43, 42, 43, 43, 43, 42, 43, 43, 43, 42, 42, 43, 42, 42, 42, 43, 42, 43, 43, 43, 43, 43, 43, 42, 43, 43, 43, 43, 43, 43, 43, 43, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 47, 45, 44, 44, 44, 45, 46, 46, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 45, 46, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 46, 47, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 47, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 44, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 44, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 46, 46, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 47, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 46, 46, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 47, 46, 46, 45, 46, 45, 45, 46, 46, 46, 47, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 47, 47, 47, 48, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 45, 46, 46, 46, 47, 46, 46, 46, 45, 46, 46, 45, 46, 46, 46, 46, 47, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 47, 46, 46, 45, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 46, 46, 46, 46, 46, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 46, 45, 45, 45, 45, 44, 45, 45, 47, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 46, 45, 45, 47, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 44, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 46, 47, 45, 45, 44, 45, 45, 45, 45, 45, 47, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 46, 45, 45, 45, 45, 44, 46, 45, 45, 45, 46, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 44, 45, 45, 46, 45, 44, 45, 45, 45, 46, 45, 45, 45, 46, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 46, 44, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 46, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 46, 44, 45, 45, 45, 45, 45, 45, 45, 44, 46, 45, 44, 45, 44, 45, 46, 45, 45, 45, 45, 45, 45, 46, 46, 45, 45, 45, 45, 45, 45, 45, 44, 46, 45, 45, 45, 44, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 44, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 44, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 46, 45, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 44, 46, 45, 45, 46, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 46, 46, 46, 46, 45, 45, 45, 45, 46, 45, 45, 46, 45, 45, 45, 45, 46, 45, 45, 45, 46, 46, 45, 45, 45, 45, 46, 45, 45, 44, 46, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 46, 45, 45, 45, 46, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 46, 45, 46, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 46, 45, 46, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 46, 46, 45, 45, 45, 44, 45, 45, 46, 45, 46, 44, 45, 44, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 46, 45, 45, 45, 45, 45, 45, 45, 47, 46, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 45, 44, 45, 46, 45, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 46, 46, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 45, 45, 45, 46, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 44, 44, 45, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 46, 44, 44, 44, 45, 44, 44, 45, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 45, 44, 44, 44, 45, 44, 44, 43, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 45, 45, 44, 45, 44, 44, 44, 44, 45, 44, 44, 45, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 44, 43, 44, 44, 43, 44, 44, 44, 45, 44, 45, 44, 44, 44, 44, 44, 44, 45, 44, 44, 43, 44, 44, 44, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 45, 46, 45, 45, 45, 45, 46, 46, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 46, 45, 45, 44, 45, 45, 45, 45, 45, 45, 44, 44, 44, 44, 44, 45, 45, 43, 45, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 45, 44, 43, 44, 43, 44, 44, 44, 45, 44, 44, 46, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 46, 45, 45, 45, 45, 46, 45, 46, 46, 45, 45, 44, 45, 45, 45, 45, 45, 46, 46, 46, 46, 47, 47, 47, 46, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 46, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 44, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 44, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 46, 45, 45, 45, 46, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 46, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 46, 47, 46, 46, 45, 46, 46, 48, 45, 46, 46, 46, 47, 47, 46, 46, 46, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 46, 46, 44, 46, 45, 44, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 44, 47, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 44, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 46, 46, 45, 45, 45, 45, 45, 45, 45, 46, 47, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 46, 45, 44, 45, 45, 46, 45, 45, 45, 44, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 45, 44, 46, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 46, 45, 47, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 47, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 46, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 46, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 48, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 47, 46, 46, 47, 47, 47, 47, 47, 47, 47, 46, 45, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 47, 46, 47, 47, 46, 46, 46, 46, 46, 46, 46, 47, 47, 47, 47, 46, 47, 47, 47, 47, 47, 46, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 48, 47, 46, 46, 46, 47, 46, 46, 46, 46, 47, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 45, 46, 46, 46, 46, 46, 47, 47, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 47, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 47, 47, 47, 46, 47, 47, 47, 47, 47, 48, 48, 48, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 46, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 47, 47, 47, 47, 47, 47, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 47, 47, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 47, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 47, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 47, 45, 45, 46, 46, 47, 46, 46, 46, 45, 46, 46, 48, 47, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 45, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 45, 46, 47, 47, 46, 46, 46, 45, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 47, 46, 46, 46, 46, 46, 46, 45, 46, 46, 48, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 48, 48, 48, 47, 48, 47, 47, 47, 47, 47, 47, 49, 47, 48, 47, 47, 47, 47, 47, 47, 46, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 49, 48, 47, 47, 47, 47, 48, 47, 47, 48, 47, 47, 46, 48, 49, 48, 48, 47, 47, 47, 48, 48, 47, 48, 47, 47, 47, 48, 47, 47, 48, 46, 47, 47, 47, 47, 47, 47, 48, 46, 47, 47, 47, 47, 47, 47, 48, 47, 47, 48, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 48, 48, 47, 48, 48, 47, 48, 47, 48, 47, 47, 47, 47, 49, 48, 48, 48, 49, 48, 47, 48, 48, 48, 48, 48, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 48, 47, 47, 46, 47, 47, 48, 47, 47, 46, 46, 47, 47, 47, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 47, 47, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 45, 46, 46, 46, 46, 46, 46, 48, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 45, 45, 45, 46, 46, 47, 47, 47, 46, 46, 46, 47, 48, 48, 47, 48, 47, 46, 46, 47, 47, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 45, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 47, 46, 46, 46, 46, 46, 46, 47, 46, 47, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 47, 46, 46, 47, 46, 46, 47, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 45, 46, 46, 47, 48, 46, 45, 46, 46, 47, 46, 46, 46, 47, 47, 47, 47, 47, 47, 47, 47, 47, 46, 47, 47, 47, 47, 47, 47, 47, 46, 47, 46, 47, 46, 46, 45, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 47, 46, 47, 46, 45, 46, 46, 47, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 47, 46, 48, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 47, 46, 47, 47, 46, 47, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 47, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 47, 47, 47, 47, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 47, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 47, 46, 46, 47, 48, 47, 46, 47, 46, 45, 45, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 47, 46, 47, 46, 46, 47, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 48, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 45, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 47, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 47, 48, 47, 46, 46, 45, 46, 46, 47, 47, 47, 47, 47, 47, 46, 47, 47, 46, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 48, 48, 47, 47, 47, 47, 48, 47, 47, 47, 47, 46, 47, 47, 48, 47, 48, 46, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 48, 48, 48, 48, 49, 49, 49, 48, 49, 49, 50, 49, 50, 49, 49, 49, 49, 49, 49, 49, 50, 49, 49, 49, 49, 49, 49, 49, 49, 48, 49, 49, 49, 50, 49, 49, 49, 48, 48, 49, 49, 50, 49, 49, 49, 50, 49, 49, 49, 49, 49, 50, 49, 49, 50, 49, 49, 49, 49, 49, 49, 50, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 50, 50, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 48, 48, 49, 49, 49, 49, 49, 50, 50, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 48, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 50, 48, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 48, 49, 49, 50, 49, 49, 49, 49, 50, 49, 49, 49, 49, 49, 50, 49, 49, 49, 49, 48, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 50, 49, 49, 49, 49, 49, 49, 50, 49, 50, 49, 49, 49, 49, 49, 49, 49, 50, 49, 49, 49, 49, 49, 49, 49, 49, 50, 49, 49, 49, 49, 49, 49, 49, 49, 50, 50, 50, 49, 48, 49, 49, 49, 49, 48, 49, 49, 50, 49, 50, 49, 49, 49, 49, 49, 50, 49, 49, 50, 50, 51, 49, 49, 49, 49, 49, 50, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 51, 50, 48, 49, 49, 48, 51, 50, 50, 51, 51, 50, 50, 51, 50, 50, 50, 50, 50, 50, 51, 50, 50, 50, 50, 51, 50, 49, 50, 50, 50, 51, 50, 49, 50, 51, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 51, 50, 50, 51, 51, 50, 50, 50, 50, 50, 50, 50, 51, 51, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 51, 50, 50, 50, 51, 50, 50, 50, 50, 50, 50, 51, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 51, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 49, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 51, 51, 51, 49, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 49, 50, 52, 51, 50, 50, 50, 50, 50, 51, 51, 51, 51, 50, 50, 50, 50, 50, 50, 50, 50, 50, 51, 50, 50, 50, 51, 50, 50, 49, 50, 50, 50, 49, 50, 50, 50, 50, 50, 50, 51, 50, 50, 51, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 51, 50, 50, 51, 50, 50, 49, 49, 50, 50, 50, 50, 50, 49, 50, 50, 50, 50, 50, 50, 50, 50, 50, 51, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 49, 50, 50, 50, 50, 50, 50, 51, 50, 50, 50, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 53, 51, 52, 50, 50, 52, 51, 51, 52, 51, 52, 50, 51, 53, 51, 51, 51, 52, 51, 52, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 53, 52, 53, 51, 51, 52, 52, 52, 52, 52, 53, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 53, 53, 52, 52, 52, 52, 52, 52, 53, 52, 54, 52, 52, 51, 52, 52, 53, 52, 51, 52, 52, 52, 52, 53, 53, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 53, 54, 53, 52, 52, 53, 52, 52, 52, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 53, 52, 52, 52, 51, 52, 52, 52, 52, 53, 52, 53, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 52, 53, 53, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 54, 52, 54, 52, 52, 52, 52, 51, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 54, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 53, 53, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 53, 52, 52, 52, 52, 53, 52, 52, 52, 53, 53, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 52, 51, 52, 52, 53, 52, 53, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 53, 53, 53, 53, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 53, 51, 52, 52, 53, 52, 52, 53, 52, 51, 51, 51, 50, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 50, 51, 51, 51, 51, 51, 50, 51, 51, 51, 51, 51, 51, 50, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 52, 51, 51, 51, 51, 52, 51, 50, 51, 52, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 50, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 53, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 52, 52, 51, 51, 50, 52, 51, 51, 51, 51, 51, 51, 51, 51, 50, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 50, 51, 51, 51, 51, 51, 51, 52, 52, 52, 52, 52, 52, 52, 51, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 53, 53, 53, 52, 52, 53, 53, 52, 52, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 51, 51, 51, 51, 51, 51, 50, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 50, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 52, 51, 52, 52, 51, 51, 50, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 50, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 50, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 50, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 50, 52, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 50, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 50, 51, 52, 52, 52, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 52, 51, 51, 51, 51, 52, 50, 51, 51, 51, 50, 51, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 53, 51, 51, 50, 51, 52, 51, 51, 51, 52, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 50, 51, 52, 52, 52, 52, 51, 51, 50, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 50, 52, 52, 52, 52, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 50, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 50, 51, 50, 51, 51, 52, 53, 52, 51, 52, 51, 51, 51, 51, 51, 51, 53, 51, 52, 52, 51, 51, 52, 51, 51, 50, 51, 51, 52, 51, 51, 51, 53, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 53, 50, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 52, 50, 51, 51, 51, 51, 51, 50, 50, 52, 52, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 52, 51, 51, 52, 52, 51, 51, 51, 51, 51, 50, 51, 51, 51, 51, 52, 51, 51, 51, 51, 50, 51, 51, 51, 51, 51, 51, 51, 53, 50, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 52, 51, 51, 51, 51, 50, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 51, 50, 51, 50, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 52, 51, 51, 51, 52, 51, 51, 51, 51, 52, 52, 51, 52, 51, 51, 50, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 52, 51, 51, 51, 51, 51, 51, 52, 51, 51, 50, 51, 50, 51, 50, 50, 50, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 52, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 52, 51, 51, 51, 51, 52, 50, 51, 51, 51, 52, 51, 51, 52, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 52, 52, 52, 51, 51, 51, 51, 51, 51, 51, 51, 52, 52, 51, 51, 51, 51, 50, 51, 51, 52, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 52, 52, 52, 52, 53, 52, 52, 52, 51, 51, 51, 51, 51, 51, 51, 52, 52, 52, 52, 51, 51, 51, 51, 51, 50, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 50, 52, 51, 52, 51, 51, 50, 51, 51, 51, 52, 51, 52, 51, 51, 51, 51, 52, 50, 52, 51, 51, 51, 50, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 52, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 53, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 51, 51, 52, 54, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 50, 50, 51, 51, 51, 50, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 50, 51, 51, 51, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 50, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 52, 51, 51, 52, 52, 51, 51, 51, 51, 51, 51, 51, 52, 52, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 53, 52, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 52, 52, 52, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 52, 51, 52, 51, 50, 51, 51, 51, 51, 51, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 51, 52, 53, 52, 52, 53, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 51, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 53, 52, 52, 53, 53, 53, 53, 54, 53, 53, 53, 53, 54, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 54, 53, 53, 53, 53, 54, 52, 53, 53, 53, 52, 53, 54, 53, 53, 52, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 54, 53, 53, 53, 52, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 54, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 52, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 52, 53, 53, 53, 53, 53, 53, 53, 53, 53, 52, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 54, 53, 53, 53, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 53, 52, 52, 52, 52, 53, 52, 52, 51, 52, 52, 51, 52, 52, 51, 52, 52, 52, 52, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 53, 52, 51, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 53, 52, 51, 52, 52, 52, 52, 52, 52, 52, 51, 51, 52, 52, 52, 52, 52, 52, 51, 52, 52, 51, 53, 52, 53, 52, 52, 52, 52, 52, 53, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 53, 53, 53, 54, 52, 53, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 52, 52, 52, 53, 53, 53, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 53, 53, 53, 53, 53, 53, 54, 53, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 53, 52, 52, 53, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 53, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 53, 54, 52, 52, 52, 53, 52, 52, 52, 55, 53, 53, 53, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 55, 54, 52, 52, 52, 52, 52, 52, 52, 53, 53, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 52, 53, 52, 53, 53, 53, 53, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 54, 52, 52, 52, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 52, 51, 52, 51, 52, 52, 52, 53, 53, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 53, 53, 52, 51, 54, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 51, 52, 53, 52, 52, 51, 51, 52, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 51, 52, 51, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 54, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 53, 52, 53, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 51, 52, 52, 53, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 53, 52, 52, 51, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 51, 52, 53, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 51, 52, 52, 53, 52, 52, 52, 52, 52, 52, 54, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 53, 52, 52, 52, 52, 52, 53, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 53, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 51, 52, 52, 53, 52, 53, 52, 52, 51, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 54, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 52, 53, 53, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 51, 52, 52, 53, 52, 52, 52, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 53, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 53, 53, 53, 52, 53, 52, 52, 52, 52, 52, 52, 55, 52, 53, 52, 52, 52, 53, 52, 52, 52, 52, 53, 53, 53, 52, 52, 52, 51, 52, 52, 52, 52, 53, 53, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 53, 53, 52, 53, 52, 52, 52, 52, 53, 51, 52, 52, 52, 51, 52, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 53, 52, 52, 52, 51, 52, 53, 52, 52, 52, 52, 53, 52, 52, 53, 52, 52, 52, 52, 52, 53, 52, 53, 52, 52, 52, 52, 52, 52, 51, 53, 52, 52, 52, 52, 53, 52, 53, 52, 52, 52, 52, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 53, 53, 53, 53, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 55, 54, 53, 53, 53, 53, 54, 53, 53, 52, 52, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 52, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 54, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 54, 54, 54, 53, 53, 53, 53, 54, 53, 53, 54, 54, 54, 53, 54, 55, 55, 54, 55, 54, 54, 54, 55, 55, 54, 54, 54, 54, 55, 55, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 55, 55, 54, 55, 55, 55, 55, 54, 53, 54, 53, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 55, 56, 55, 55, 55, 54, 53, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 55, 54, 54, 54, 54, 54, 55, 55, 54, 54, 55, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 55, 54, 53, 54, 54, 55, 54, 55, 55, 55, 54, 54, 53, 54, 55, 55, 56, 54, 54, 53, 54, 55, 54, 54, 56, 54, 54, 54, 54, 54, 54, 54, 54, 55, 55, 54, 54, 54, 54, 54, 54, 55, 54, 54, 54, 56, 55, 55, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 55, 54, 54, 54, 54, 55, 54, 54, 54, 54, 53, 54, 54, 55, 54, 54, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 52, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 54, 54, 55, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 52, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 52, 53, 53, 53, 54, 53, 53, 53, 52, 53, 52, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 54, 53, 53, 53, 52, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 54, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 52, 53, 54, 53, 52, 53, 54, 53, 53, 54, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 52, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 55, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 52, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 52, 53, 53, 53, 53, 52, 53, 54, 53, 54, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 52, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 52, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 54, 54, 54, 52, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 54, 53, 53, 53, 54, 55, 53, 53, 52, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 52, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 52, 53, 53, 53, 54, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 52, 53, 53, 53, 52, 53, 52, 52, 52, 52, 53, 52, 51, 52, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 54, 52, 52, 52, 52, 52, 52, 53, 52, 52, 53, 52, 52, 52, 54, 53, 53, 53, 53, 53, 53, 54, 54, 53, 53, 53, 54, 53, 53, 53, 52, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 52, 53, 53, 54, 53, 53, 53, 52, 53, 53, 54, 53, 53, 53, 54, 53, 53, 52, 53, 53, 54, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 52, 52, 53, 53, 53, 53, 53, 54, 53, 53, 53, 52, 53, 52, 53, 53, 53, 52, 53, 53, 53, 53, 53, 53, 53, 53, 52, 53, 53, 52, 53, 53, 53, 53, 53, 54, 53, 53, 53, 54, 54, 53, 52, 53, 53, 53, 54, 55, 54, 54, 54, 54, 53, 54, 54, 54, 54, 53, 53, 53, 54, 52, 53, 53, 54, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 52, 53, 53, 53, 52, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 52, 53, 53, 52, 53, 53, 53, 53, 56, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 52, 53, 54, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 52, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 54, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 54, 53, 54, 53, 52, 53, 53, 53, 52, 53, 53, 53, 55, 53, 53, 53, 53, 52, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 52, 52, 53, 53, 55, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 54, 53, 53, 53, 53, 53, 52, 53, 54, 54, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 52, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 54, 54, 54, 54, 55, 54, 53, 53, 52, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 52, 53, 53, 53, 54, 53, 54, 53, 53, 53, 53, 53, 54, 54, 53, 53, 52, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 54, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 54, 53, 54, 53, 53, 53, 54, 54, 54, 54, 54, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 54, 54, 53, 53, 53, 53, 54, 54, 54, 54, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 55, 54, 54, 53, 53, 54, 53, 53, 53, 53, 54, 53, 54, 55, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 52, 53, 53, 53, 53, 53, 53, 53, 54, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 54, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 54, 53, 53, 52, 54, 54, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 54, 54, 54, 54, 54, 53, 54, 54, 53, 53, 53, 53, 53, 53, 55, 55, 53, 53, 53, 53, 53, 52, 53, 53, 53, 53, 53, 55, 54, 54, 54, 53, 54, 53, 53, 54, 54, 53, 53, 54, 53, 53, 52, 53, 53, 53, 53, 53, 54, 53, 52, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 52, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 54, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 54, 54, 55, 54, 54, 54, 54, 54, 54, 54, 55, 54, 54, 54, 54, 54, 54, 54, 55, 54, 54, 54, 54, 54, 54, 55, 54, 54, 54, 55, 55, 53, 53, 53, 52, 53, 53, 53, 53, 53, 53, 52, 53, 53, 53, 53, 53, 53, 53, 53, 54, 52, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 54, 54, 53, 53, 53, 53, 53, 52, 53, 53, 54, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 54, 52, 54, 53, 53, 54, 53, 53, 53, 53, 53, 53, 54, 53, 54, 52, 53, 54, 53, 53, 53, 53, 54, 53, 54, 54, 54, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 52, 53, 53, 53, 53, 53, 53, 55, 53, 53, 53, 53, 54, 54, 53, 54, 53, 53, 53, 54, 53, 53, 54, 53, 53, 53, 52, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 56, 52, 53, 53, 53, 53, 53, 53, 53, 53, 54, 54, 52, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 54, 53, 53, 53, 52, 53, 53, 53, 53, 55, 53, 53, 53, 53, 53, 53, 52, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 54, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 52, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 54, 54, 53, 55, 53, 54, 53, 53, 54, 54, 53, 53, 53, 53, 53, 52, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 52, 53, 53, 54, 53, 53, 53, 54, 54, 52, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 52, 53, 53, 53, 53, 53, 54, 53, 54, 53, 53, 53, 53, 53, 53, 53, 54, 55, 55, 54, 54, 55, 53, 53, 53, 53, 53, 52, 53, 54, 53, 53, 53, 54, 53, 53, 53, 52, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 55, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 54, 54, 53, 53, 52, 53, 53, 53, 53, 53, 53, 53, 53, 52, 53, 53, 53, 54, 53, 53, 53, 53, 53, 52, 53, 53, 54, 53, 53, 54, 53, 53, 54, 53, 53, 52, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 52, 53, 53, 53, 53, 52, 53, 53, 53, 53, 53, 53, 53, 53, 52, 53, 54, 53, 54, 53, 53, 53, 53, 53, 53, 52, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 55, 53, 54, 54, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 55, 54, 54, 54, 54, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 54, 52, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 54, 53, 54, 53, 53, 53, 54, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 52, 53, 53, 53, 52, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 52, 53, 53, 54, 54, 54, 54, 54]
Topic Token Allocation Count (sum=7.68434972E8):
[42891545, 25333149, 25302653, 24819837, 24531242, 24333570, 23436394, 23406450, 22221109, 22118304, 21625132, 20840196, 20632026, 20489131, 20073286, 19962884, 19606783, 18815218, 18772841, 18486215, 18058176, 17481535, 16992126, 16958779, 16804047, 16453295, 15589621, 14974499, 14902097, 13624471, 13436332, 13009769, 12471027, 12265425, 11936118, 11724096, 10818765, 10644025, 10433023, 8916984, 8818401, 6010906, 4985579, 4850805, 4346265, 3994566, 235352, 464, 281, 112, 53, 9, 3, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
Topic Token Allocation Count (%):
[0.0558, 0.0330, 0.0329, 0.0323, 0.0319, 0.0317, 0.0305, 0.0305, 0.0289, 0.0288, 0.0281, 0.0271, 0.0268, 0.0267, 0.0261, 0.0260, 0.0255, 0.0245, 0.0244, 0.0241, 0.0235, 0.0227, 0.0221, 0.0221, 0.0219, 0.0214, 0.0203, 0.0195, 0.0194, 0.0177, 0.0175, 0.0169, 0.0162, 0.0160, 0.0155, 0.0153, 0.0141, 0.0139, 0.0136, 0.0116, 0.0115, 0.00782, 0.00649, 0.00631, 0.00566, 0.00520, 0.000306, 0.000000604, 0.000000366, 0.000000146, 0.0000000690, 0.0000000117, 0.00000000390, 0.00000000130, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000]
Topic Token Allocation CDF (%):
[0.0558, 0.0888, 0.1217, 0.1540, 0.1859, 0.2176, 0.2481, 0.2786, 0.3075, 0.3363, 0.3644, 0.3915, 0.4184, 0.4450, 0.4712, 0.4971, 0.5227, 0.5471, 0.5716, 0.5956, 0.6191, 0.6419, 0.6640, 0.6861, 0.7079, 0.7293, 0.7496, 0.7691, 0.7885, 0.8062, 0.8237, 0.8406, 0.8569, 0.8728, 0.8884, 0.9036, 0.9177, 0.9316, 0.9451, 0.9567, 0.9682, 0.97604, 0.98253, 0.98884, 0.99449, 0.99969, 0.999999, 0.999999403, 0.999999768, 0.999999914, 0.9999999831, 0.9999999948, 0.99999999870, 1.00000000000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000]
Thu Sep 24 06:20:45 BST 2020: I am done!
Build info:Implementation-Build = 21f3fa031204320aa15d4613c5a67a1c833b26e8, Implementation-Version = 8.0.6
